drugset
Drugs / Dexmedetomidine
last change yesterday re-read 2 minutes ago

Dexmedetomidine

English name dexmedetomidine
also known as DEX · Precedex · Dexmedetomidine Hydrochloride · BXCL501 · Dexdor · DXM · dexmedetomidin · Dexmedetomidine Injection · +38 more

Other / unclassified targets ADRA2A via activation

Developed for
delirium · infectious disease with sepsis · sleep disorder · anxiety · chronic pain syndrome · obesity disorder · acute kidney injury · breast cancer
+156 more · gallbladder disorder · neuropathy, painful · obstructive sleep apnea syndrome · schizophrenia · coronary artery disorder · respiratory failure · schizoaffective disorder · cardiac rhythm disease · cognitive disorder · congenital heart disease · hypospadias · hypotensive disorder · osteoarthritis, knee · schizophreniform disorder · traumatic brain injury · acute lung injury · brain neoplasm · hypertensive disorder · insomnia · ischemic disease · post-traumatic stress disorder · subacute delirium · supratentorial cancer · benign shuddering attacks · bipolar disorder · heart disorder · osteoarthritis, hip · spinal stenosis · substance withdrawal syndrome · tetralogy of fallot · tonsillitis · vertebral column disorder · acute stress disorder · alcohol-related disorders · arthropathy · atrial fibrillation · bipolar I disorder · bipolar II disorder · brain aneurysm · brain hypoxia - ischemia · cancer · central nervous system disorder · chronic obstructive pulmonary disease · colorectal cancer · critical illness polyneuropathy · dementia · headache disorder · pharyngitis · pregnancy disorder · strabismus · subjective cognitive decline · acquired aneurysmal subarachnoid hemorrhage · acute respiratory distress syndrome · acute respiratory failure · alcohol withdrawal · aortic valve stenosis · autism spectrum disorder · brain injury · cardiac valvular defect · cataract · cerebrovascular disorder · cleft lip/palate · cleft palate · heart valve disorder · inflammatory disease · intermediate coronary syndrome · ischemic stroke · kidney failure · mental disorder · neonatal respiratory failure · neurodevelopmental disorder · pain agnosia · paralytic ileus · postgastrectomy syndrome · postpartum depression · respiratory system disorder · Riley-Day syndrome · thyroid gland disorder · type 2 diabetes mellitus · acute coronary syndrome · acute necrotizing pancreatitis · adolescent idiopathic scoliosis · alcohol withdrawal delirium · Alzheimer disease · amyotrophic lateral sclerosis · anxiety disorder · arthropathy, erosive · asthma · atrial septal defect · bone disorder · carpal tunnel syndrome · CGF1 · childhood malignant neoplasm · cocaine intoxication · cognitive impairment with or without cerebellar ataxia · congenital deformities of limbs · crush syndrome · dental caries · disorder of defective peroxisome oxidative status · encephalopathy, acute, infection-induced · fibromyalgia · glaucoma · glucose intolerance · hemorrhagic disease · herpes zoster · impaired renal function disease · infective endocarditis · interstitial cystitis · intestinal disorder · intracerebral hemorrhage · kidney disorder · leiomyoma · lumbar disk disease · lung disorder · major depressive disorder · myocardial infarction · nasal disorder · neurological pain disorder · nicotine dependence · PDA1 · peripheral nerve lesion · pituitary tumor · post-surgical hypoinsulinemia · potassium deficiency · progressive non-infectious anterior vertebral fusion · pulmonary hypertension · reactive airway disease · restrictive pulmonary disease · retinal detachment · separation anxiety disorder · sleep-wake disorder · substance-induced psychosis · upper thoracic spina bifida aperta · urinary tract obstruction · autoinflammatory syndrome · cleft lip · digestive system disorder · endotheliitis · esophageal varices with bleeding · hemopneumothorax · intracranial hypotension · isolated female hypospadias · mild pre-eclampsia · mitochondrial disease · mixed anxiety and depressive disorder · movement disorder · myocardial ischemia · non-functioning pituitary adenoma · preeclampsia · spondylosis, cervical · ST-elevation myocardial infarction · thrombotic disease · tympanic membrane disorder · vascular hemostatic disease · ventricular fibrillation · ventricular tachycardia
Investigated by
Peking University First Hospital · Tanta University · Yonsei University · Assiut University · Cairo University · Ain Shams University
+653 more · Pfizer · BioXcel Therapeutics Inc · Seoul National University Hospital · National Taiwan University Hospital · Beijing Tiantan Hospital · Guangzhou General Hospital of Guangzhou Military Command · Massachusetts General Hospital · Mansoura University · Benha University · Chinese Medical Association · Cognitive Research Corporation · Eye & ENT Hospital of Fudan University · Kafrelsheikh University · NYU Langone Health · Orion Corporation, Orion Pharma · Poznan University of Medical Sciences · Alexandria University · China Medical University, China · National Cancer Institute, Egypt · Ruijin Hospital · Sahiwal medical college sahiwal · West China Hospital · Anqing Municipal Hospital · Children's Hospital Medical Center, Cincinnati · Children's Hospital of Philadelphia · Chinese PLA General Hospital · Kaohsiung Medical University Chung-Ho Memorial Hospital · Kasr El Aini Hospital · National Heart, Lung, and Blood Institute (NHLBI) · Qianfoshan Hospital · Second Affiliated Hospital, School of Medicine, Zhejiang University · Shanghai Zhongshan Hospital · Sindh Institute of Urology and Transplantation · Tang-Du Hospital · The First Affiliated Hospital of Anhui Medical University · University of British Columbia · University of Turku · Yale University · Zagazig University · Al-Azhar University · Anesthesia Research Group UA · Baylor College of Medicine · Beijing Hospital · Beijing Jishuitan Hospital · Boston Children's Hospital · Changhai Hospital · China International Neuroscience Institution · Fudan University · Gangnam Severance Hospital · General Hospital of Ningxia Medical University · Helwan University · Indonesia University · Insel Gruppe AG, University Hospital Bern · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Maruishi Pharmaceutical · Nanjing First Hospital, Nanjing Medical University · Nationwide Children's Hospital · Peking University Shenzhen Hospital · Peking University Third Hospital · Post Graduate Institute of Medical Education and Research, Chandigarh · RenJi Hospital · Shanghai Pulmonary Hospital, Shanghai, China · Sheikh Zayed Medical College · Southeast University, China · Udayana University · University Medical Centre Ljubljana · University of California, San Francisco · Xijing Hospital · Ajou University School of Medicine · Aydin Adnan Menderes University · Baudax Bio · Beijing Friendship Hospital · Brigham and Women's Hospital · Capital Medical University · all 659 on the full record

Regulatory milestones approvals, filings & regulatory actions · 7 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansion US (FDA) IGALMI — 2025-11-19 fda.gov ↗
Label expansions (3) US (FDA) PRECEDEX — 2008-10-17 – 2022-12-16 fda.gov ↗
Label expansion US (FDA) DEXMEDETOMIDINE HYDROCHLORIDE — 2016-09-19 fda.gov ↗
Approved EU (EMA) Dexdor — 2011-09-15 europa.eu ↗
Approved US (FDA) PRECEDEX — 1999-12-17 fda.gov ↗

Trials 1,064 · started per year

today
US approved 1999
EU approved 2011
1
3
6
12
9
9
14
13
24
39
27
67
49
62
70
52
60
59
80
66
73
102
97
69
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 031 trials
Phase 0 NCT06824077 Aug 2026 → Mar 2027 expected delirium University of Alberta Not yet recruiting No outcome recorded
Phase 0 NCT07211399 Jul 2026 → Dec 2030 substance-related disorder Jacques E. Chelly Withdrawn No outcome recorded
Phase 0 NCT07502651 May 2025 → Mar 2027 expected — Postgraduate Institute of Dental Sciences Rohtak Enrolling by invitation No outcome recorded
Phase 0 NCT06756178 Jan 2025 → Nov 2026 expected delirium Assiut University Not yet recruiting No outcome recorded
Phase 0 NCT05264077 Nov 2024 → Jun 2025 overdue — Sheikh Zayed Medical College Not yet recruiting No outcome recorded
Phase 0 NCT06229054 Feb → Jul 2024 — Cairo University Completed No outcome recorded
Phase 0 NCT06215768 Jan → Sep 2024 delirium Esraa Abdel Azez Soltan Mohamed Zayed Unknown No outcome recorded
Phase 0 NCT07651488 Mar → Sep 2023 — Liaquat National Hospital & Medical College Completed No outcome recorded
Phase 0 NCT05505630 Jan 2023 → Dec 2025 nicotine dependence Wake Forest University Health Sciences Completed No outcome recorded
Phase 0 NCT05574179 Jan → Jul 2023 — Sheikh Zayed Medical College Unknown No outcome recorded
Phase 143 trials
Phase 1 NCT05619627 Aug 2026 → Aug 2027 expected — Children's Mercy Hospital Kansas City Not yet recruiting No outcome recorded
Phase 1 NCT07167316 May → Dec 2026 expected — Hans-Peter Landolt Recruiting No outcome recorded
Phase 1 NCT07603596 May 2026 → Apr 2028 expected delirium, digestive system neoplasm Qianfoshan Hospital Not yet recruiting No outcome recorded
Phase 1 NCT07677917 Jan → Jul 2026 overdue — Ain Shams University Enrolling by invitation No outcome recorded
Phase 1 NCT06335407 Jul 2025 → Mar 2026 overdue alcohol-related disorders, post-traumatic stress disorder Pharmacotherapies for Alcohol and Substance Use Disorders Alliance Recruiting No outcome recorded
Phase 1 NCT07023991 May → Aug 2025 overdue — Ain Shams University Enrolling by invitation No outcome recorded
Phase 1 NCT07140627 Aug 2024 → Jan 2025 — Allama Iqbal Medical College Completed No outcome recorded
Phase 1 NCT06304909 May 2024 → Mar 2025 — Assiut University Completed No outcome recorded
Phase 1 NCT06631625 Sep 2023 → Sep 2024 — Alexandria University Completed No outcome recorded
Phase 1 NCT07051512 Jul 2023 → Jun 2024 — Tanta University Completed No outcome recorded
Phase 1/217 trials
Phase 1/2 NCT07672301 Mar 2026 → Jun 2027 expected — University of Chicago Recruiting No outcome recorded
Phase 1/2 NCT07622355 Sep 2025 → Jun 2026 overdue thyroid gland disorder The Second People's Hospital of Huai'an Active not recruiting No outcome recorded
Phase 1/2 NCT06970678 Apr → Jun 2025 overdue — Alexandria University Recruiting No outcome recorded
Phase 1/2 NCT07024043 Mar → Sep 2025 overdue — Ain Shams University Active not recruiting No outcome recorded
Phase 1/2 NCT07099222 Oct 2024 → Dec 2026 expected constipation disorder University of Arizona Active not recruiting No outcome recorded
Phase 1/2 NCT06545890 Aug → Nov 2024 overdue delirium Cairo University Recruiting No outcome recorded
Phase 1/2 NCT06712186 Jun → Nov 2024 overdue anxiety disorder, hypertensive disorder Liaquat National Hospital & Medical College Recruiting No outcome recorded
Phase 1/2 NCT04824144 Jan 2024 → Jan 2026 overdue delirium Bruyère Health Research Institute. Recruiting No outcome recorded
Phase 1/2 NCT05712707 Feb 2023 → Jun 2025 overdue substance withdrawal syndrome New York State Psychiatric Institute Active not recruiting No outcome recorded
Phase 1/2 NCT04926454 Sep 2020 → Oct 2021 neuropathy, painful Ain Shams University Unknown No outcome recorded
Phase 265 trials
Phase 2 NCT07705022 Jul 2026 → Jan 2028 expected — University of Michigan Not yet recruiting No outcome recorded
Phase 2 NCT07588802 Jul 2026 → Apr 2027 expected — Massachusetts General Hospital Not yet recruiting No outcome recorded
Phase 2 NCT06943404 Feb → Sep 2026 expected acute stress disorder, post-traumatic stress disorder University of North Carolina, Chapel Hill Recruiting No outcome recorded
Phase 2 NCT07392177 Feb 2026 → Mar 2027 expected insomnia Woolcock Institute of Medical Research Not yet recruiting No outcome recorded
Phase 2 NCT07249827 Dec 2025 → Jun 2026 — McGill University Health Centre/Research Institute of the McGill University Health Centre Completed No outcome recorded
Phase 2 NCT07519863 Nov 2025 → Nov 2026 expected — Ain Shams University Recruiting No outcome recorded
Phase 2 NCT05057689 Sep → Oct 2025 acute stress disorder, anxiety Nationwide Children's Hospital Withdrawn No outcome recorded
Phase 2 NCT07168720 Aug 2025 → Mar 2026 overdue — Guangzhou Novaken Pharm Co., Ltd. Recruiting No outcome recorded
Phase 2 NCT06985290 Jul 2025 → Sep 2027 expected brain hypoxia - ischemia Ipsita Goswami Not yet recruiting No outcome recorded
Phase 2 NCT07116694 Jun → Oct 2025 bipolar I disorder, bipolar II disorder, schizoaffective disorder, schizophrenia +1 BioXcel Therapeutics Inc Completed No outcome recorded
Phase 2/350 trials
Phase 2/3 NCT07537894 Jul 2026 → Jul 2027 post-traumatic stress disorder, pregnancy disorder with abortive outcome Stanford University Withdrawn No outcome recorded
Phase 2/3 NCT07493785 Jun 2026 → Aug 2032 expected neonatal respiratory failure, neurodevelopmental disorder Centre Hospitalier Intercommunal Creteil Not yet recruiting No outcome recorded
Phase 2/3 NCT07538284 May → Dec 2026 expected delirium, sleep disorder Sixth Affiliated Hospital, Sun Yat-sen University Not yet recruiting No outcome recorded
Phase 2/3 NCT07555821 Apr → Oct 2026 expected — South Egypt Cancer Institute Not yet recruiting No outcome recorded
Phase 2/3 NCT06935292 Apr 2025 → Apr 2026 overdue — Tanta University Not yet recruiting No outcome recorded
Phase 2/3 NCT06799442 Mar → Dec 2025 overdue — Assiut University Not yet recruiting No outcome recorded
Phase 2/3 NCT07290595 Jan 2025 → Feb 2026 overdue hypotensive disorder Sahiwal medical college sahiwal Recruiting No outcome recorded
Phase 2/3 NCT06752616 Dec 2024 → Dec 2027 expected — Lone Baandrup Recruiting No outcome recorded
Phase 2/3 NCT06662175 Nov 2024 → Jul 2025 overdue — Lady Reading Hospital, Pakistan Not yet recruiting No outcome recorded
Phase 2/3 NCT06899841 Oct 2024 → Oct 2025 overdue — Assiut University Recruiting No outcome recorded
Phase 3103 trials
Phase 3 NCT07569536 Sep 2026 → Oct 2028 expected infectious disease with sepsis Hospices Civils de Lyon Not yet recruiting No outcome recorded
Phase 3 NCT07434310 Jul 2026 → Jul 2027 expected inflammatory bowel disease Dr. Naveed Siddiqui Not yet recruiting No outcome recorded
Phase 3 NCT07627906 Jul → Dec 2026 expected delirium Cairo University Recruiting No outcome recorded
Phase 3 NCT07542990 Apr 2026 → Apr 2029 expected delirium University Hospital, Tours Not yet recruiting No outcome recorded
Phase 3 NCT07327879 Jan → Nov 2026 expected benign shuddering attacks Al-Azhar University Not yet recruiting No outcome recorded
Phase 3 NCT06878703 Oct 2025 → Dec 2027 expected — Assistance Publique - Hôpitaux de Paris Recruiting No outcome recorded
Phase 3 NCT07184801 Oct 2025 → Oct 2026 expected — Post Graduate Institute of Medical Education and Research, Chandigarh Recruiting No outcome recorded
Phase 3 NCT06259565 Jul 2025 → Dec 2029 expected — St. Joseph's Healthcare Hamilton Recruiting No outcome recorded
Phase 3 NCT06875427 Jul 2025 → Jan 2027 expected — Isabella Jaramillo Recruiting No outcome recorded
Phase 3 NCT07426081 Jun → Nov 2025 — Patel Hospital, Pakistan Completed No outcome recorded
Phase 4398 trials
Phase 4 NCT07597109 Sep 2026 expected arterial disorder Insel Gruppe AG, University Hospital Bern Not yet recruiting No outcome recorded
Phase 4 NCT07644663 Jun → Aug 2026 overdue — Fudan University Not yet recruiting No outcome recorded
Phase 4 NCT07570160 Jun 2026 → Nov 2027 expected — Nanjing Children's Hospital Not yet recruiting No outcome recorded
Phase 4 NCT07306702 Jun 2026 → May 2027 — Shenyang Sixth People's Hospital Withdrawn No outcome recorded
Phase 4 NCT07579806 Jun → Dec 2026 expected delirium Sichuan Provincial People's Hospital Not yet recruiting No outcome recorded
Phase 4 NCT07576517 Jun 2026 → Jun 2029 expected cognitive disorder Peking University First Hospital Not yet recruiting No outcome recorded
Phase 4 NCT07567495 Jun 2026 → May 2028 expected — Columbia University Not yet recruiting No outcome recorded
Phase 4 NCT07639099 Jun 2026 → Oct 2029 expected postpartum depression Peking University First Hospital Not yet recruiting No outcome recorded
Phase 4 NCT07610343 Jun 2026 → Nov 2027 expected cognitive impairment with or without cerebellar ataxia, sleep disorder Peking University First Hospital Not yet recruiting No outcome recorded
Phase 4 NCT07576543 Jun 2026 → Jun 2030 expected cognitive disorder Peking University First Hospital Not yet recruiting No outcome recorded
Show all 398 trials opens the full record — a long page
Phase not applicable357 trials
— NCT07657715 Aug 2026 → Dec 2027 expected infectious disease with sepsis First Affiliated Hospital of Wannan Medical College Not yet recruiting No outcome recorded
— NCT07695220 Jul 2026 → Oct 2028 expected intracerebral hemorrhage The Third Affiliated Hospital of Southern Medical University Not yet recruiting No outcome recorded
— NCT07677215 Jul 2026 → Sep 2027 expected osteoarthritis, knee Poznan University of Medical Sciences Not yet recruiting No outcome recorded
— NCT07678216 Jul 2026 → Jun 2028 expected traumatic brain injury Aswan University Not yet recruiting No outcome recorded
— NCT07699523 Jun 2026 → Jun 2027 expected electroencephalographic peculiarity: fronto-precentral beta wave groups China-Japan Friendship Hospital Not yet recruiting No outcome recorded
— NCT07636070 Jun → Aug 2026 overdue urolithiasis murat sahin Not yet recruiting No outcome recorded
— NCT07675616 May → Dec 2026 expected lacrimal duct obstruction Cairo University Recruiting No outcome recorded
— NCT07565116 May → Aug 2026 overdue — Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital Recruiting No outcome recorded
— NCT07501221 May 2026 → Jun 2027 expected — Chengdu Jinjiang Maternity and Child Health Hospital Not yet recruiting No outcome recorded
— NCT07501728 May 2026 → Jan 2027 expected postpartum depression Chengdu Jinjiang Maternity and Child Health Hospital Not yet recruiting No outcome recorded
Show all 357 trials opens the full record — a long page
Also used as a comparator or background therapy in 730 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 018 trials
Phase 0 NCT07485127 Comparator Feb → Aug 2026 overdue — Sohag University Active not recruiting No outcome recorded
Phase 0 NCT07012213 Comparator Oct → Nov 2025 overdue — Cairo University Not yet recruiting No outcome recorded
Phase 0 NCT06741566 Comparator Dec 2024 → May 2026 overdue — Minia University Recruiting No outcome recorded
Phase 0 NCT06607861 Comparator Jun 2024 → Jun 2026 overdue — Minia University Recruiting No outcome recorded
Phase 0 NCT05829148 Comparator May 2023 → Nov 2024 — Egymedicalpedia Unknown No outcome recorded
Phase 134 trials
Phase 1 NCT07380139 Comparator Feb → Dec 2026 expected — Ain Shams University Enrolling by invitation No outcome recorded
Phase 1 NCT07279727 Comparator Jan → Dec 2026 expected — Assiut University Not yet recruiting No outcome recorded
Phase 1 NCT07332130 Comparator Dec 2025 → Jan 2026 overdue — Minia University Hospital Not yet recruiting No outcome recorded
Phase 1 NCT06958367 Comparator Nov 2025 → Nov 2026 expected — Ain Shams University Active not recruiting No outcome recorded
Phase 1 NCT07669012 Comparator Oct 2025 → Oct 2026 expected — Ain Shams University Recruiting No outcome recorded
Phase 1/220 trials
Phase 1/2 NCT06490731 Comparator Apr → Jun 2026 overdue — New Valley University Recruiting No outcome recorded
Phase 1/2 NCT07180095 Comparator Jan → Jun 2026 overdue — Liaquat National Hospital & Medical College Not yet recruiting No outcome recorded
Phase 1/2 NCT07101367 Comparator Sep 2025 → Aug 2026 overdue autoinflammatory syndrome, coronary artery disorder Ain Shams University Not yet recruiting No outcome recorded
Phase 1/2 NCT07432997 Comparator Dec 2023 → Sep 2024 Alzheimer disease Applied Cognition Completed No outcome recorded
Phase 1/2 NCT06077539 Comparator Sep 2023 → Apr 2024 subacute delirium Cairo University Unknown No outcome recorded
Phase 251 trials
Phase 2 NCT07550881 Comparator Apr → Dec 2026 expected anxiety Tongji University Recruiting No outcome recorded
Phase 2 NCT07465185 Comparator Mar → Sep 2026 expected — Benha University Recruiting No outcome recorded
Phase 2 NCT07443085 Comparator Feb 2026 → Jul 2027 expected delirium Benha University Recruiting No outcome recorded
Phase 2 NCT06052254 Comparator Sep 2025 → May 2027 expected — Teikoku Pharma USA, Inc. Recruiting No outcome recorded
Phase 2 NCT06936410 Comparator Mar 2025 → Mar 2026 — Cairo University Completed No outcome recorded
Phase 2/341 trials
Phase 2/3 NCT06970626 Comparator Apr → Jun 2025 overdue — Alexandria University Recruiting No outcome recorded
Phase 2/3 NCT06427707 Comparator Jun → Oct 2024 overdue esophageal varices with bleeding Ain Shams University Recruiting No outcome recorded
Phase 2/3 NCT06830564 Comparator May → Nov 2024 delirium Ain Shams University Completed No outcome recorded
Phase 2/3 NCT07434206 Comparator Apr 2024 → Mar 2026 overdue thyroid tumor South Egypt Cancer Institute Active not recruiting No outcome recorded
Phase 2/3 NCT06082076 Comparator Nov 2023 → Nov 2024 — Assiut University Unknown No outcome recorded
Phase 376 trials
Phase 3 NCT07573969 Comparator May 2026 → May 2027 expected — Ain Shams University Recruiting No outcome recorded
Phase 3 NCT07443163 Comparator Mar → Sep 2026 expected — Cairo University Not yet recruiting No outcome recorded
Phase 3 NCT07326397 Comparator Feb 2026 → Nov 2027 expected — Assiut University Not yet recruiting No outcome recorded
Phase 3 NCT07330375 Comparator Jan → Jun 2026 overdue — Zagazig University Not yet recruiting No outcome recorded
Phase 3 NCT07213037 Comparator Nov 2025 → Nov 2026 expected — Assiut University Not yet recruiting No outcome recorded
Phase 4215 trials
Phase 4 NCT07377981 Comparator Aug 2026 → Jan 2029 expected — The First Affiliated Hospital with Nanjing Medical University Not yet recruiting No outcome recorded
Phase 4 NCT07651956 Comparator Jun 2026 → May 2028 expected anxiety Icahn School of Medicine at Mount Sinai Not yet recruiting No outcome recorded
Phase 4 NCT07369128 Comparator Jun 2026 → Dec 2027 expected subacute delirium Boston Children's Hospital Recruiting No outcome recorded
Phase 4 NCT07611890 Comparator May → Aug 2026 overdue — Rawalpindi Institute of Cardiology Recruiting No outcome recorded
Phase 4 NCT07179913 Comparator May → Nov 2026 expected depressive disorder The First Hospital of Jilin University Active not recruiting No outcome recorded
Show all 215 trials opens the full record — a long page
Phase not applicable275 trials
— NCT07486336 Comparator Sep 2026 → Sep 2028 expected cognitive disorder Ente Ospedaliero Ospedali Galliera Not yet recruiting No outcome recorded
— NCT07398066 Comparator Jul 2026 → Jul 2027 expected brain cancer, meningioma University of Malaya Not yet recruiting No outcome recorded
— NCT07640516 Comparator Jul 2026 → Jan 2027 expected — Kasr El Aini Hospital Recruiting No outcome recorded
— NCT07665463 Background Jul → Dec 2026 expected — Jagiellonian University Not yet recruiting No outcome recorded
— NCT07683416 Comparator Jul 2026 → Jan 2027 expected — Zagazig University Not yet recruiting No outcome recorded
Show all 275 trials opens the full record — a long page

Evidence & citations 51 cited values

Every value below carries the sentence it was read from. 1,837 sources stand behind the page.

FieldValueCited text
Known as dexmedetomidine “Dexmedetomidine-esketamine combination (1 μg/mL dexmedetomidine and 0.5 mg/mL esketamine) will be administered after anesthesia induction, firstly as a loading dose at a rate...” NCT07576517 ↗
1774

“Dexmedetomidine is a potent selective α 2 adrenoceptor agonist that was reported in many previous studies as an adjunct to regional and general anesthesia, with significant...” NCT05385523 ↗

“The aim of this study will be to investigate the population pharmacokinetics and pharmacodynamics of rectal dexmedetomidine Niosomes for Postoperative Analgesia in Pediatric...” NCT05340725 ↗

“Dexmedetomidine, a novel α2-agonist with an eight-fold affinity for α2-adrenergic receptors (sedate and analgesic effects) as clonidine, while exerts much less α1-effects., has...” NCT05727098 ↗

“patients who will receive intravenous (I.V.) ketamine in a dose of 0.25 mg/kg diluted in 5 ml normal saline plus dexmetedomidine 0.25ug/kg followed by infusion of...” NCT07513935 ↗

“General anesthesia without intraoperative opioids using dexmedetomidine, ketamine, lidocaine, sevoflurane, non-opioid co-analgesics, procedure-specific regional analgesia, and...” NCT07665463 ↗

“Patient will be given a peripheral nerve block from their treating anesthesiologist before the operation (in the OR) with an conventional ultrasound guided femoral and sciatic...” NCT04697537 ↗

“The investigators will not mandate the sedative type, but rather encourage the use of sedatives that are already routinely used in participating ICUs (typically a...” NCT05849779 ↗

“Dexmedetomidine,an α2 adrenergic agonist,has hypnotic,analgesic, anxiolytic,antisympathetic effects,which could facilitate the sedation of patients while maintaining their...” NCT02613806 ↗

“Dexmedetomidine is a highly selective alpha-2 adrenergic receptor agonist that reduces the release of norepinephrine by inhibiting activity in the locus coeruleus, a key brain...” NCT07167316 ↗

“Intravenous Induction of Anesthesia Using a Mixture of Ketamine and dexmedetomidine in a ratio of 1 mg ketamine to 0.5 ug dexmedetomidine given in a dose of 1mg/kg ketamine and...” NCT07002073 ↗

“Dexmedetomidine (DEX) an α-2 adrenergic receptor agonist, because its sympatholytic and antinociceptive properties may ensure optimal intraoperative hemodynamic stability...” NCT03132259 ↗

“Then , they will receive ketamine 0.1 mg/kg /hr and dexmedetomidine0.2ug/kg/hr in their maintenance syringes prepared in 20 ml normal saline in a concentration of 1mg/ml...” NCT05402189 ↗

“Dexmedetomidine (Precedex) is a highly selective alpha 2 adrenoreceptor agonist which produce sedation, anxiolysis, analgesia, and decreasing inflammatory response to...” NCT06514040 ↗

“Group D: : will receive dexmedetomidine (1 μg/kg) diluted in 5ml normal saline sprayed via long nostril syringe into oropharynx , the vocal cords and tracheobronchial tree 5...” NCT06374017 ↗

“Minimal infusion rates of dexmedetomidine (0.1-0.4 μg/kg/h) in the D group and fentanyl (0.01-0.05 μg/kg/min) in the PF group were continued during colonoscopy, which lasted...” NCT06148103 ↗

“The use of dexmedetomidine in these patient populations may explain the high rate of hypotension reported in a recent study in trauma patients where almost 50% of patients had...” NCT03285087 ↗

“Trans-foraminal Lumbar Epidural Injection of Dexmedetomidine Against Magnesium Sulfate When Combined With Dexamethasone in Uni-lateral Lower Limb Radicular Pain. Multi-centeric...” NCT05271721 ↗

“dexmedetomidine ( administered intravenously, Load: 0.25 mcg/kg IV over 10 minutes , Maintenance 0.2-0.7 mcg/kg/hr continuous IV infusion according to haemodynamics and...” NCT06653244 ↗

“Standard of Care analgosedation of choice using propofol, fentanyl, dexmedetomidine, morphine, hydromorphone, midazolam, or lorazepam administered according to the...” NCT06429657 ↗

“A pre-prepared 50 ml syringe is utilized, containing 400 mcg of dexmedetomidine (4 ml), 50 mg of S-ketamine (2 ml), 400 mg of 2% lidocaine (20 ml), and 0.9% NaCl to a total...” NCT07084753 ↗

“After endotracheal intubation, anesthesia was maintained with 1.5-3% sevoflurane, 0.3-0.5 μg/kg/h dexmedetomidine and 2-4 μg/mL target-controlled infusion of remifentanil in...” NCT04680650 ↗

“Patients in the TIVA group had anesthesia induced with propofol 2 mg/kg , fentanyl 1 ug/kg and maintained with propofol. 200 ug/kg/min, fentanyl 0.1ug/kg/min, dexmedetomidine 1...” NCT06423846 ↗

“Dexmedetomidine has been shown to improve myocardial perfusion, reduce arrhythmia incidence, reduce inflammatory response, and reduce mortality in patients with coronary artery disease.” NCT03601091 ↗

“the study aim to compare the analgesic effect of intravenous dexmedetomidine and fascia iliaca block preoperatively to assist positioning patients for performance of spinal anesthesia.” NCT05705726 ↗

“The primary objective of this study is to evaluate the analgesic efficacy of Dexmedetomidine Transdermal System (DMTS), compared with placebo, in participants following abdominoplasty.” NCT04242407 ↗

“Recent studies have shown very promising results in terms of efficacy and duration of block by mixing bupivacaine with dexmedetomidine, alongwith minimal side effects to the patients.” NCT05244252 ↗

“Group A: Caudal Dexmedetomidine block group (DEXM) (n= 16) will receive caudal block using the bupivacaine 0.25% and Dexmedetomidine 1 μg/kg with the conventional general anesthesia,” NCT03101137 ↗

“All subjects in this arm receive Dexmedetomidine with a prepared concentration of 10 μg/mL. A loading dose of 1.0 μg/kg is administered by infusion and completed within 10 minutes.” NCT07644663 ↗

“IV 0.2 mic/ kg of dexmedetomidine will be diluted over 10 ml saline and given to the patient over 10 minutes before induction and assess the feasibility of classic LMA insertion” NCT07562308 ↗

“Dexmedetomidine is a selective, specific, lipophilic and potent α2 adrenergic receptor agonist with sedative, anxiolytic, analgesic, antihypertensive and sympatholytic effects.” NCT03479216 ↗

“This study will be conducted to investigate the efficacy of adding dexmedetomidine in STB for postoperative analgesia in patients undergoing arthroscopic shoulder surgery.” NCT07046325 ↗

“Dexmedetomidine is new highly selective α2 adrenoceptor agonist and has been approved by Food and Drug Administration as intravenous (IV) sedative and co-analgesic drug.” NCT06970574 ↗

“Compare the opioid based anesthesia with Fentanyl and Remifentanyl to opioid free anesthesia with dexmedetomidine and lidocaine and their effect on postoperative pain.” NCT03417193 ↗

“Patients will receive a scalp block with a 20 ml syringe containing 1 mg/kg of 0.5% bupivacaine and 1 µg/kg of dexmedetomidine, with the remainder filled with saline.” NCT07698665 ↗

“Patients received general anesthesia and bilateral ultrasound guided transmuscular quadratus lumborum block with (20ml Bupivacaine 0.25%) + (Dexmedetomidine Imic/kg)” NCT06825286 ↗

“Total IntraVenous Anesthesia - to achieve deep-sedation via chemical analgesic (propofol, dexmedetomidine, fentanyl, hydromorphone); continuous intravenous infusion.” NCT07672301 ↗

“Dexmedetomidine, a highly selective alpha2-adrenoceptor agonist used for short-term sedation of mechanically ventilated patients, has minimal effect on ventilation.” PMID 15505441 ↗ Nov 2004

“GROUP A will receive Dexmedetomidine in dose of of 0.5μg/ kg/hour It elicits a biphasic blood pressure response: a short hypertensive phase followed by hypotension.” NCT04917029 ↗

“Dexmedetomidine is a highly selective, alpha2-adrenergic receptor agonist that has been widely used for adult anesthesia and as a sedative in intensive care units.” NCT05786833 ↗

“Dexmedetomidine (Dexamed) is a selective α2-adrenoceptor agonist with sedative and neuroprotective properties, known to reduce ICP without respiratory depression .” NCT07199595 ↗

“may use a combination of fentanyl, midazolam, dexmedetomidine infusion (with or without loading dose), and/or low-dose propofol by intermittent bolus or infusion” NCT03263117 ↗

“Patients will be nebulized with mixture of 2% lidocaine 10 ml and dexmedetomidine 1 μg/kg by using wall nebulizer for 15 min before awake fiberoptic intubation.” NCT06088875 ↗

“ketamine (1mg/kg) prepared for concentration 10mg/ml, Dexmedetomidine (0.5microg/kg slow IV) prepared for concentration of 5mic /ml in 2 separate syringes.” NCT05948267 ↗

“Dexmedetomidine ,an alfa-2 adrenoreceptor agonist, is being used and adjuvant capable of prolonging duration of sensory and motor block on nerve blocks.” NCT02544893 ↗

“Patients received a loading dose of dexmedetomidine at 1 µg/kg over 10 minutes, followed by a continuous infusion at 1 µg/kg/h throughout the procedure.” NCT05581485 ↗

“Group B: Patients who will receive transversus abdominis plane block with - 18ml Bupivacaine 0.25%+ 2ml Dexmedetomidine (1µg/Kg diluted in 2ml saline).” NCT07590752 ↗

“Dexmedetomidine, a selective α2-adrenoreceptor agonist, was shown to be a potent antinociceptive agent when given intrathecally in animals and humans.” PMID 23727917 ↗ 2013

“Dexmedetomidine or Hyalase : Which of Them Can Augment Lumbar Epidural Steroid Injection in Failed Back Surgery Patients. A Randomized Clinical Trial” NCT05370963 ↗

“Dexmedetomidine is a drug used for sedation in critically ill patients that provides some pain relief and controls the bodies response to stress.” NCT01934049 ↗

“The investigators will use vasopressin as the primary vasopressor and a heart rate-calibrated dexmedetomidine infusion in septic shock patients.” NCT06302998 ↗

“Patients were randomly allocated to receive either intravenous dexmedetomidine (1 μg/kg) or dexamethasone (8 mg) after induction of anesthesia.” NCT07426081 ↗

“Use of deeper plane of inhaled anesthetics or adjuncts (opioids, propofol, dexmedetomidine or ketamine for maintenance of general anesthesia.” NCT03962725 ↗

“Studies showed dexmedetomidine (DEX) could improve surgical field, but the effect for functional nasal endoscopic surgery (FESS) was unclear.” NCT04276545 ↗

“Sedation was induced with a dexmedetomidine 0.5μg/kg over 10 min loading, followed by a maintenance infusion of 0.2-0.7 μg/kg/h for one hour.” NCT01447875 ↗

“Two syringes containing ketodex-ketamine (1 mg/kg) and dexmedetomidine (1 µg/kg)-each diluted with 0.9% saline and infused over 10 minutes.” NCT07246447 ↗

“Dexmedetomidine is a potent and highly selective alpha-2 receptor agonist with sympatholytic, sedative, amnestic, and analgesic properties.” NCT06592027 ↗

“All patients were administered a bolus of ketamine (0.5 mg/kg) and were started continuous infusion dexmedetomidine at a dose 0.7 μg/kg/h.” NCT05514652 ↗

“Dexmedetomidine (trade name Precedex) is approved by U.S. Food and Drug Administration (FDA) and indicated for sedation (calming effect).” NCT01969903 ↗

“Peroperative opioid free anesthesia will be obtained via a combination of dexmedetomidine, ketamine, lidocaine and magnesium sulfate” NCT03124680 ↗

“In the Total i.v. anaesthesia (TIVA) group (n=60), patients underwent opioid-free TIVA with propofol, ketamine, and dexmedetomidine.” PMID 24554545 ↗ Feb 2014

“BioXcel Therapeutics has developed BXCL501 (dexmedetomidine: sublingual film) to reduce symptoms associated with opioid withdrawal.” NCT05712707 ↗

“Intravenous sedation in control group will be continued as initiated at the ICU e.g. propofol, fentanyl, midazolam, dexmedetomidine” NCT04355962 ↗

“One prospect is dexmedetomidine (Precedex®), which is FDA-approved for short-term (≤24 hours) sedation in the intensive care unit.” NCT01007773 ↗

“Dex group: Dexmedetomidine 2mcg/ml-containing 1% lidocaine scalp injection by neurosurgeon(dosage: according to incision length)” NCT01606969 ↗

“The DEX Group, consisting of 29 patients, received 2.5 ml of hyperbaric bupivacaine mixed with dexmedetomidine (10 μg; 0.5 ml).” NCT06216197 ↗

“dexmedetomidine was infused under ECG monitoring at an initial rate of 0.5 μ G/kg (more than 10min), then changed to 0.2ug/kg/h” NCT05577962 ↗

“Patients in this group will receive errector spine plane block with 30 ml bupivacaine 0.25% plus 1ml of 1µg/kg Dexmedetomidine” NCT04650737 ↗

“Dexmedetomidine (DEXM) is a highly selective α2-adrenoceptor agonist that has been used increasingly in pediatric anesthesia.” NCT03791879 ↗

“Dexmedetomidine is a highly selective alpha 2 adrenergic receptor agonist with sedative, analgesic, and anxiolytic effects.” NCT07576543 ↗

“Analgesia will be offered by syringe containing ketamine and Dexmedetomidine in induction and maintenance according to IBW.” NCT06650371 ↗

“Dexmedetomidine is a highly selective α2-adrenergic receptor agonist with sedative, anxiolytic, and analgesic properties.” NCT07166614 ↗

“If systolic BP is still ≥ 140 mmHg, then dexmedetomidine will be applied using an infusion pump at a dose of 0.2 μg/kg/h.” NCT03207100 ↗

“bupivacaine 0.25% and dexmedetomidine 0.5 mcg/mL (total volume of 10 mL) by epidural-catheter bolus given preoperatively” NCT05069311 ↗

“Group II received 20 ml of 0.25% bupivacaine with supplementation of 1 mL containing 100µg dexmedetomidine bilaterally” NCT03746418 ↗

“continuous intravenous infusion of ketamine (5 μg/kg/min) and dexmedetomidine (0.6 μg/kg/h) during general anesthesia.” NCT07588802 ↗

“Parasternal block with Bupivacaine 0.25% + Epinephrine 1:200,000 x 60cc + Dexamethasone 5mg and Dexmedetomidine 50mcg” NCT05191745 ↗

“In the D1 group, patients were administered 20 mL of 0.25% isobaric bupivacaine with 0.5 mcg/kg of dexmedetomidine.” NCT06703229 ↗

“Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type” NCT06052254 ↗

“Group (D): (n=30) will receive Dexmedetomidine infusion 0.1- 0.2 μg/kg/hour titrated to desired level of sedation.” NCT05474183 ↗

“the use of dexmedetomidine as a pharmacological treatment for delirium in critical illness patients with covid-19” NCT05963958 ↗

“Group D (n=80) will receive dexmedetomidine 0.5 µg/kg i.v. (Precedex®, Hospira Inc, USA, Vials of 200 mg/2 ml)” NCT06627816 ↗

“Dexmedetomidine, a highly selective α2-adrenergic receptor agonist, offers several advantages as an adjuvant.” NCT06769737 ↗

“Anesthesia is maintained with continuous infusion of propofol 1.5-2mg/kg/h and dexmedetomidine 0.2-1ug/kg/h.” NCT02739958 ↗

“will receive bupivacaine 0.25% (3ml) + dexmedetomidine (1 mic/kg), total volume 5ml by adding normal saline” NCT07380139 ↗

“A mixture of 0.5 ml /kg bupivacaine (0.25%), and 0.5µg/Kg dexmedetomidine and Epinephrine 5 microgram/ ml.” NCT03408184 ↗

“Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty” NCT05412992 ↗

“Patients will receive adjuvant dexmedetomidine (25mcg) and dexamethasone (5mg) in addition to bupivacaine.” NCT06658054 ↗

“one under complete intravenous anesthesia (infusion of Propofol, Ketamine, Lignocaine and Dexmedetomidine)” NCT06390046 ↗

“An opioid-free general anesthetic technique utilizing dexmedetomidine, ketamine, and lidocaine infusions” NCT02752477 ↗

“Dexmedetomidine (DEX) is a selectiveα2 adrenergic receptor agonist with sedative and analgesic effects.” NCT07125573 ↗

“Total intravenous anesthesia with propofol and dexmedetomidine hydrochloride and ketamine hydrochloride” NCT04144153 ↗

“Caudal block will be performed with 0.75ml/kg of 0.25% bupivacaine containing 1 mic/kg dexmedetomidine.” NCT05233683 ↗

“Intraoperative continuous intravenous infusion of 2-6 mg/kg/h propofol, 0.5-1.0 μg/kg/h dexmedetomidine” NCT07603596 ↗

“Continuous infustion of dexmedetomidine at 0.2 ~ 1.0 mcg/kg/hr with sevoflurane concentration of 1 MAC” NCT01634594 ↗

“Effect of Dexmedetomidine on Gastric Emptying, Assessed by Ultrasound in Laparoscopic Cholecystectomy” NCT06634524 ↗

“Dexmedetomidine (Pfizer, Kirkland, Quebec), single-dose, 4 mcg/kg (0.04 mL/kg) of 100 mcg/mL solution” NCT04195256 ↗

“Effect of intra-articular dexmedetomidine on postoperative analgesia after arthroscopic knee surgery.” PMID 18567675 ↗ Jun 2008

“Anesthesia will be maintained with dexmedetomidine infusion at 0.2-1.4 µg/kg/h and 1 MAC sevoflurane.” NCT07105839 ↗

“Participants will receive a dexmedetomidine infusion in addition to low dose sevoflurane anesthesia.” NCT05369949 ↗

“Subjects will receive standard of care anesthesia Sevoflurane, with intravenous push Dexmedetomidine” NCT06624592 ↗

“Subjects will be given a rectus sheath block containing dexmedetomidine, ropivacaine, and ketorolac” NCT03817034 ↗

“1µg/kg of dexmedetomidine is given 30 minutes prior to intravenous cannulation or lumbar puncture” NCT03564093 ↗

“It is composed by Dexmedetomidine (Dexdor), Lidocaine, Magnesium Sulfate and ketamine (Ketolar).” NCT05887258 ↗

“Dexmedetomidine is an alpha-2 adrenoceptor agonist with analgesic and neuroprotec-tive effects.” NCT07074262 ↗

“•Group D (Dexmedetomidine Group): 0.5 µg/kg dexmedetomidine diluted in 100 mL of normal saline.” NCT07377903 ↗

“Dexmedetomidine Transdermal System (DMTS) for Post-Operative Analgesia Following Bunionectomy” NCT02953054 ↗

“Infusing Dexmedetomidine which load dose 0.5μg/kg in 10min then changed into 0.5-1.0μg/kg•h” NCT02727712 ↗

“TIVA opioid-free anesthesia: dexmedetomidine 1-1.5 mcg/kg (corrected weight) for 40 minutes” NCT04854252 ↗

“In group A,patients will be given 0.25% bupivacaine 1 mL/kg with dexmedetomidine0.5 μg/kg.” NCT06735443 ↗

“a conscious sedation group (dexmedetomidine) and a general anesthesia group (desflurane).” NCT05550714 ↗

“Dexmedetomidine and lidocaine are administered during anesthesia, and opioid is not used.” NCT05076903 ↗

“Group A : will receive bupivacaine 0.25% + dexmedetomidine 1 mic/kg, total volume (20 ml)” NCT06294665 ↗

“plus dexmedetomidineIV bolus 1 μg/kg/10min + infusion pump 0.5 μg /kg/hrs intraoperative” NCT05474040 ↗

“Dexmedetomidine (DEX), is a selective centrally acting α 2-adrenergic receptors agonist” NCT04709315 ↗

“Sedation based on dexmedetomidine and low dosage of ketamine, avoiding GABAergic-drugs” NCT07486336 ↗

“Dexmedetomidine will be injected (1 mcg/kg for 10 minutes and afterward 0.3 mcg/kg/hr)” NCT01991223 ↗

“Patients will receive Ketodex (ketamine- dexmedetomidine mixture in a ratio of 1:1).” NCT07627906 ↗

“dexmedetomidine 1 mic/kg IV over 10 minutes then 0.4 mic/kg/h continuous IV infusion” NCT05619965 ↗

“During surgery, 0.5mcg/kg of dexmedetomidine and 0.1mg/kg ondansetron will be given.” NCT03467750 ↗

“Dexmedetomidine may be an alternative to current drug therapies for breathlessness.” NCT02773797 ↗

“Dexmedetomidine may be an alternative to current drug therapies for breathlessness.” NCT02211118 ↗

“Anesthesia maintenance: Desflurane set at \~1 MAC, Dexmedetomidine 0.2-1.2mcg/kg/h” NCT04894864 ↗

“use of dexmedetomidine as an adjuvant to the patient-controlled propofol sedation” NCT01070680 ↗

“Anesthesia induction: Dexmedetomidine 1µg/kg (intravenous infusion within 10min)” NCT04507165 ↗

“Infusion of dexmedetomidine(1μg/kg) at 10 minutes before anesthesia induction.” NCT02289391 ↗

“Dexmedetomidine Hydrochloride is a high selected a-2 adrenoreceptor agonists.” NCT02691598 ↗

“Intravenous sedation using propofol or dexmedetomidine will be administered.” NCT03404180 ↗

“Infusion of dexmedetomidine at 0.4 μg•kg-1•h-1during anesthesia maintenance.” NCT02143362 ↗

“Dexmedetomidine is a potent and highly selective α2-adrenoreceptor agonist.” NCT05897307 ↗

“lidocaine and dexmedetomidine infusion in 50 ml syringe till end of surgery” NCT05850468 ↗

“Dexmedetomidine (DXM) is a recently released and approved alpha 2 agonist” NCT02102139 ↗

“patients will receive dexmedetomidine 0.2-0.7 mcg/kg/h infusion for 24h.” NCT03285165 ↗

“0.4 mcg/kg dexmedetomidine, max total dose 50mcg in 50 ml N/S infusion” NCT05752799 ↗

“0.3 mcg Kg-1 (actual weight) of dexmedetomidine IV in 20 mL of saline” NCT06289335 ↗

“1 mcg/kg Dexmedetomidine, max total dose 100mcg in 50 ml N/S infusion” NCT07568938 ↗

“Injectable 1 ml/kg of 0.25% ropivacaine with 1mcg/kg dexmedetomidine” NCT05708989 ↗

“Dexmedetomidine is a selective alpha two adreno-receptor agonist.” NCT05291364 ↗

“Dexmedetomidine is a potent alpha-2 adrenergic receptor agonist.” NCT05119101 ↗

“dexmedetomidine bolus dose of 1 mcg/kg followed by 0.3 mcg/kg/h” NCT05962671 ↗

“50 mcg Dexmedetomidine (0.5 cc of standard 100 mcg/ml solution)” NCT06343753 ↗

“Dexmedetomidine 0.5 ug/kg + Propofol + Sevoflurane+ Vecuronium” NCT01584570 ↗

“Sublingual film containing 180 µg of Igalmi (dexmedetomidine)” NCT06041646 ↗

“(1 mL/kg of bupivacaine 0.25% plus 1 μ/kg dexmedetomidine).” NCT03482947 ↗

“Dexmedetomidine 1mcg/kg IV bolus over 10 minutes using IBW” NCT04081545 ↗

“Midazolam, Dexmedetomidine, Lidocaine, Propofol, Ketamine” NCT05172739 ↗

“Dexmedetomidine (DEX) is an alpha-2 adrenoceptor agonist” NCT06793150 ↗

“1. IV dexmedetomidine 2. IV ketamine Both for sedation” NCT03954379 ↗

“loading dose of dexmedetomidine, intravenous midazolam” NCT06493396 ↗

“adding dexmedetomidine 5 μg in the saline component” NCT05525819 ↗

“Dexmedetomidine loading dose 1 μg/kg i.v. infusion.” NCT04941040 ↗

“dexmedetomidine for sedation and sympatholysis” NCT07310524 ↗

“will receive nebulized Dexmedetomidine 3 µg/kg” NCT05872087 ↗

“group (F) receive dexmedetomidine and ketamine” NCT07360327 ↗

“Precedex, dexmedetomidine hydrochloride” NCT04082767 ↗

“Dexmedetomidine as a sedation drug” NCT04142502 ↗

“Administration of Dexmedetomidine” NCT01337739 ↗

“Dexmedetomidine Intranasal Spray” NCT03348423 ↗

“dexmedetomidine (12-20 mcg IV)” NCT07211399 ↗

“Dexmedetomidine 1mcg/kg IV” NCT04197570 ↗

“dexmedetomidine” NCT03596424 ↗

“Dexmedetomidine” NCT06176222 ↗

“Dexmedetomidine” NCT06410404 ↗

“dexmedetomidine” NCT05658692 ↗

NCT07395271 ↗

NCT00333632 ↗

NCT05590234 ↗

NCT05091151 ↗

NCT00538616 ↗

NCT05505630 ↗

NCT04694105 ↗

NCT01901588 ↗

NCT06090955 ↗

NCT05591001 ↗

NCT02016391 ↗

NCT01132794 ↗

NCT02469961 ↗

NCT05031026 ↗

NCT07509866 ↗

NCT05361642 ↗

NCT02923128 ↗

NCT01057381 ↗

NCT02353169 ↗

NCT02783846 ↗

NCT07510217 ↗

NCT05594407 ↗

NCT04314050 ↗

NCT01498380 ↗

NCT04608331 ↗

NCT04018157 ↗

NCT03677115 ↗

NCT04987372 ↗

NCT05781854 ↗

NCT05828199 ↗

NCT02164448 ↗

NCT07639099 ↗

NCT06575179 ↗

NCT03788018 ↗

NCT06865469 ↗

NCT02077712 ↗

NCT05751304 ↗

NCT05829148 ↗

NCT04955249 ↗

NCT02495220 ↗

NCT05554848 ↗

NCT05552391 ↗

NCT07306702 ↗

NCT04385602 ↗

NCT00455143 ↗

NCT07241351 ↗

NCT02699801 ↗

NCT07012590 ↗

NCT04076826 ↗

NCT07117565 ↗

NCT05863416 ↗

NCT00351299 ↗

NCT06752317 ↗

NCT02845661 ↗

NCT02004613 ↗

NCT04734418 ↗

NCT06551259 ↗

NCT03425734 ↗

NCT03827408 ↗

NCT06978192 ↗

NCT04498351 ↗

NCT06752616 ↗

NCT06752629 ↗

NCT07035223 ↗

NCT02842437 ↗

NCT04763434 ↗

NCT02757625 ↗

NCT05264077 ↗

NCT02537366 ↗

NCT04364945 ↗

NCT03883347 ↗

NCT05089526 ↗

NCT02222636 ↗

NCT03643796 ↗

NCT03095469 ↗

NCT03261921 ↗

NCT02375191 ↗

NCT07184801 ↗

NCT06406829 ↗

NCT07086690 ↗

NCT05304598 ↗

NCT07683416 ↗

NCT04871308 ↗

NCT07640516 ↗

NCT01929252 ↗

NCT06575530 ↗

NCT05469529 ↗

NCT03643822 ↗

NCT04678050 ↗

NCT01269918 ↗

NCT02818621 ↗

NCT06148311 ↗

NCT06402019 ↗

NCT06086431 ↗

NCT04442906 ↗

NCT06799442 ↗

NCT03343873 ↗

NCT05595083 ↗

NCT06946277 ↗

NCT03545516 ↗

NCT05305248 ↗

NCT01657812 ↗

NCT03063671 ↗

NCT01766089 ↗

NCT02753205 ↗

NCT06366412 ↗

NCT03892122 ↗

NCT06331182 ↗

NCT06981949 ↗

NCT00747721 ↗

NCT06752863 ↗

NCT01920542 ↗

NCT06711913 ↗

NCT02162433 ↗

NCT05596552 ↗

NCT06587620 ↗

NCT05752903 ↗

NCT02031510 ↗

NCT06505772 ↗

NCT07307625 ↗

NCT05168280 ↗

NCT00405847 ↗

NCT05389852 ↗

NCT04148599 ↗

NCT07274670 ↗

NCT03255824 ↗

NCT02518789 ↗

NCT02846090 ↗

NCT04766047 ↗

NCT05598177 ↗

NCT00871624 ↗

NCT00815893 ↗

NCT04873596 ↗

NCT02801188 ↗

NCT03118076 ↗

NCT03885804 ↗

NCT04113720 ↗

NCT07308756 ↗

NCT07002723 ↗

NCT05262166 ↗

NCT03610893 ↗

NCT05941767 ↗

NCT03770013 ↗

NCT07012213 ↗

NCT04946396 ↗

NCT05864404 ↗

NCT03270033 ↗

NCT04127500 ↗

NCT05746351 ↗

NCT01505933 ↗

NCT01852539 ↗

NCT03086213 ↗

NCT06720220 ↗

NCT04576975 ↗

NCT04346290 ↗

NCT07108764 ↗

NCT02225054 ↗

NCT06550414 ↗

NCT04607525 ↗

NCT05099055 ↗

NCT03393988 ↗

NCT03014713 ↗

NCT06498700 ↗

NCT01373021 ↗

NCT02987985 ↗

NCT02698930 ↗

NCT02818569 ↗

NCT05743725 ↗

NCT03807297 ↗

NCT06909305 ↗

NCT01005433 ↗

NCT02466022 ↗

NCT01195116 ↗

NCT03406546 ↗

NCT02331563 ↗

NCT00926705 ↗

NCT03406533 ↗

NCT05998551 ↗

NCT04577430 ↗

NCT07445451 ↗

NCT07508202 ↗

NCT02917018 ↗

NCT04374318 ↗

NCT04322760 ↗

NCT01887184 ↗

NCT03117790 ↗

NCT03216759 ↗

NCT03307590 ↗

NCT06943404 ↗

NCT04767256 ↗

NCT03029715 ↗

NCT06164314 ↗

NCT02807467 ↗

NCT02366299 ↗

NCT01645098 ↗

NCT03892512 ↗

NCT01948336 ↗

NCT02203019 ↗

NCT00398827 ↗

NCT06619912 ↗

NCT01904760 ↗

NCT03096730 ↗

NCT06327399 ↗

NCT04149626 ↗

NCT05123170 ↗

NCT07114263 ↗

NCT06942884 ↗

NCT02878837 ↗

NCT04251910 ↗

NCT06326983 ↗

NCT03378973 ↗

NCT07230197 ↗

NCT04213833 ↗

NCT05848505 ↗

NCT04445636 ↗

NCT02267538 ↗

NCT05041270 ↗

NCT07443163 ↗

NCT02496650 ↗

NCT01548209 ↗

NCT06899841 ↗

NCT07443085 ↗

NCT06808295 ↗

NCT06720337 ↗

NCT03089905 ↗

NCT06560892 ↗

NCT03653832 ↗

NCT03996148 ↗

NCT00641563 ↗

NCT04926454 ↗

NCT03806777 ↗

NCT03213743 ↗

NCT04674241 ↗

NCT05769530 ↗

NCT01517932 ↗

NCT07214701 ↗

NCT06111300 ↗

NCT03135795 ↗

NCT03979469 ↗

NCT00878345 ↗

NCT07441421 ↗

NCT06335407 ↗

NCT06427707 ↗

NCT00800826 ↗

NCT07162649 ↗

NCT02606409 ↗

NCT04730609 ↗

NCT00345384 ↗

NCT03316339 ↗

NCT05604599 ↗

NCT04730596 ↗

NCT05671081 ↗

NCT06169475 ↗

NCT05303987 ↗

NCT06082856 ↗

NCT06866145 ↗

NCT05785689 ↗

NCT02447796 ↗

NCT07144215 ↗

NCT04668456 ↗

NCT03923075 ↗

NCT03892928 ↗

NCT04730375 ↗

NCT04912518 ↗

NCT04058899 ↗

NCT05742438 ↗

NCT06082232 ↗

NCT02784626 ↗

NCT04037774 ↗

NCT02148432 ↗

NCT02256319 ↗

NCT06082076 ↗

NCT04968392 ↗

NCT06081933 ↗

NCT06464393 ↗

NCT07213037 ↗

NCT01050699 ↗

NCT04048226 ↗

NCT04771637 ↗

NCT02818985 ↗

NCT02300649 ↗

NCT03394430 ↗

NCT04048200 ↗

NCT04211298 ↗

NCT03417999 ↗

NCT03435003 ↗

NCT06958913 ↗

NCT00216190 ↗

NCT02880540 ↗

NCT04111926 ↗

NCT06910644 ↗

NCT06482125 ↗

NCT07519863 ↗

NCT06755996 ↗

NCT01569048 ↗

NCT04539314 ↗

NCT03363425 ↗

NCT01059929 ↗

NCT01091818 ↗

NCT04665453 ↗

NCT00383890 ↗

NCT07034898 ↗

NCT05124067 ↗

NCT06896721 ↗

NCT03989609 ↗

NCT06756178 ↗

NCT00468052 ↗

NCT04646317 ↗

NCT05271253 ↗

NCT05481970 ↗

NCT00848393 ↗

NCT01445639 ↗

NCT00095251 ↗

NCT00479661 ↗

NCT03063073 ↗

NCT06756594 ↗

NCT07522736 ↗

NCT04758936 ↗

NCT04961281 ↗

NCT05993975 ↗

NCT04729868 ↗

NCT05029050 ↗

NCT06942000 ↗

NCT06641206 ↗

NCT06756971 ↗

NCT02509949 ↗

NCT02819089 ↗

NCT02080169 ↗

NCT02678728 ↗

NCT05484648 ↗

NCT06639659 ↗

NCT07523321 ↗

NCT05672225 ↗

NCT06468436 ↗

NCT02168439 ↗

NCT06977425 ↗

NCT02670954 ↗

NCT06738043 ↗

NCT00654329 ↗

NCT05937282 ↗

NCT02863861 ↗

NCT06501352 ↗

NCT03530371 ↗

NCT06394375 ↗

NCT05610774 ↗

NCT07459322 ↗

NCT05485519 ↗

NCT02757495 ↗

NCT06367660 ↗

NCT07249827 ↗

NCT04772222 ↗

NCT03770130 ↗

NCT04115449 ↗

NCT02631135 ↗

NCT07024043 ↗

NCT01851005 ↗

NCT02799589 ↗

NCT01805726 ↗

NCT03936205 ↗

NCT07214714 ↗

NCT07099222 ↗

NCT00409344 ↗

NCT04838379 ↗

NCT02996058 ↗

NCT04327726 ↗

NCT06363578 ↗

NCT07179913 ↗

NCT07316166 ↗

NCT07434310 ↗

NCT04436731 ↗

NCT07434206 ↗

NCT06464263 ↗

NCT01463332 ↗

NCT06382831 ↗

NCT06830564 ↗

NCT05487196 ↗

NCT05466708 ↗

NCT02684019 ↗

NCT04223219 ↗

NCT06003218 ↗

NCT02439905 ↗

NCT02674737 ↗

NCT04208516 ↗

NCT07144007 ↗

NCT01255904 ↗

NCT06077539 ↗

NCT07432997 ↗

NCT05247177 ↗

NCT05446623 ↗

NCT06655025 ↗

NCT03426527 ↗

NCT03335527 ↗

NCT06958718 ↗

NCT05311722 ↗

NCT05664542 ↗

NCT06875427 ↗

NCT04891458 ↗

NCT01001429 ↗

NCT06382961 ↗

NCT04494828 ↗

NCT03065530 ↗

NCT06076759 ↗

NCT04621526 ↗

NCT06139692 ↗

NCT07081581 ↗

NCT07276867 ↗

NCT06076668 ↗

NCT02630290 ↗

NCT06737458 ↗

NCT02523144 ↗

NCT05249153 ↗

NCT05788393 ↗

NCT04111328 ↗

NCT01545297 ↗

NCT05935657 ↗

NCT05615194 ↗

NCT07525934 ↗

NCT05615727 ↗

NCT04735965 ↗

NCT05616364 ↗

NCT03918889 ↗

NCT02819141 ↗

NCT02169336 ↗

NCT04757675 ↗

NCT01760967 ↗

NCT03024957 ↗

NCT00714857 ↗

NCT03393403 ↗

NCT03204006 ↗

NCT03145714 ↗

NCT04081909 ↗

NCT07525999 ↗

NCT02464722 ↗

NCT03382938 ↗

NCT07057193 ↗

NCT05935293 ↗

NCT03463083 ↗

NCT06181682 ↗

NCT01140529 ↗

NCT06849466 ↗

NCT07164326 ↗

NCT04535089 ↗

NCT06636578 ↗

NCT00205712 ↗

NCT04206059 ↗

NCT07194694 ↗

NCT03155646 ↗

NCT06531603 ↗

NCT06183073 ↗

NCT03639896 ↗

NCT02365857 ↗

NCT07427446 ↗

NCT07165483 ↗

NCT03953677 ↗

NCT04932746 ↗

NCT05732064 ↗

NCT07080229 ↗

NCT07151716 ↗

NCT03163238 ↗

NCT05383495 ↗

NCT03013634 ↗

NCT04411329 ↗

NCT03788538 ↗

NCT00646646 ↗

NCT07023991 ↗

NCT04454515 ↗

NCT02515890 ↗

NCT06185127 ↗

NCT05246371 ↗

NCT00654511 ↗

NCT04697745 ↗

NCT05487742 ↗

NCT02713191 ↗

NCT02653144 ↗

NCT07506044 ↗

NCT07022821 ↗

NCT06878703 ↗

NCT04051099 ↗

NCT01701778 ↗

NCT06318546 ↗

NCT06093451 ↗

NCT05934669 ↗

NCT05314569 ↗

NCT04205539 ↗

NCT03498092 ↗

NCT04621110 ↗

NCT07425444 ↗

NCT06186895 ↗

NCT06684535 ↗

NCT05246007 ↗

NCT03323593 ↗

NCT03800641 ↗

NCT06409104 ↗

NCT02988050 ↗

NCT06981494 ↗

NCT03117023 ↗

NCT04329091 ↗

NCT02522858 ↗

NCT02844894 ↗

NCT02643017 ↗

NCT01871129 ↗

NCT05242692 ↗

NCT06139926 ↗

NCT06879288 ↗

NCT05619627 ↗

NCT03025295 ↗

NCT03324490 ↗

NCT05164627 ↗

NCT04016740 ↗

NCT04836819 ↗

NCT04095013 ↗

NCT04204798 ↗

NCT02134093 ↗

NCT02282319 ↗

NCT03869047 ↗

NCT01519167 ↗

NCT07013955 ↗

NCT04669457 ↗

NCT03067740 ↗

NCT05004519 ↗

NCT06761092 ↗

NCT07532733 ↗

NCT01508455 ↗

NCT05489900 ↗

NCT02225210 ↗

NCT05974527 ↗

NCT00971178 ↗

NCT04969705 ↗

NCT01188551 ↗

NCT05243940 ↗

NCT05450497 ↗

NCT04892420 ↗

NCT02097407 ↗

NCT06936410 ↗

NCT01937611 ↗

NCT03067896 ↗

NCT02284672 ↗

NCT06834841 ↗

NCT03600493 ↗

NCT06736483 ↗

NCT03171740 ↗

NCT03760809 ↗

NCT01864187 ↗

NCT00480740 ↗

NCT06736392 ↗

NCT01266252 ↗

NCT04144933 ↗

NCT06740903 ↗

NCT04409964 ↗

NCT03834129 ↗

NCT05079672 ↗

NCT00561678 ↗

NCT06067958 ↗

NCT04955158 ↗

NCT06067893 ↗

NCT00886275 ↗

NCT04648540 ↗

NCT01850017 ↗

NCT06005363 ↗

NCT06192615 ↗

NCT02581566 ↗

NCT03738059 ↗

NCT04635098 ↗

NCT07649746 ↗

NCT02624401 ↗

NCT05727969 ↗

NCT03645603 ↗

NCT03521167 ↗

NCT02599168 ↗

NCT06991647 ↗

NCT07285083 ↗

NCT04018703 ↗

NCT01495481 ↗

NCT07302815 ↗

NCT02848157 ↗

NCT06762860 ↗

NCT02874378 ↗

NCT03507634 ↗

NCT05134363 ↗

NCT02412150 ↗

NCT06093893 ↗

NCT05793060 ↗

NCT03126422 ↗

NCT01927640 ↗

NCT07078201 ↗

NCT02459509 ↗

NCT03163693 ↗

NCT04875039 ↗

NCT02546765 ↗

NCT06480539 ↗

NCT02563288 ↗

NCT02111421 ↗

NCT02289261 ↗

NCT01921361 ↗

NCT06935292 ↗

NCT02487355 ↗

NCT07180095 ↗

NCT02867930 ↗

NCT01342328 ↗

NCT02536014 ↗

NCT06785285 ↗

NCT07034300 ↗

NCT03521505 ↗

NCT03346226 ↗

NCT02092012 ↗

NCT01116700 ↗

NCT01981369 ↗

NCT06315634 ↗

NCT07166666 ↗

NCT07169227 ↗

NCT02768610 ↗

NCT06476600 ↗

NCT06410365 ↗

NCT07611890 ↗

NCT01664520 ↗

NCT06138574 ↗

NCT06423859 ↗

NCT07465185 ↗

NCT04200235 ↗

NCT05622656 ↗

NCT05843344 ↗

NCT01289769 ↗

NCT00894751 ↗

NCT04618965 ↗

NCT05874245 ↗

NCT03302351 ↗

NCT05320705 ↗

NCT05875077 ↗

NCT05273671 ↗

NCT05321121 ↗

NCT05511415 ↗

NCT06848595 ↗

NCT04724759 ↗

NCT07058493 ↗

NCT05175781 ↗

NCT07131579 ↗

NCT07537894 ↗

NCT05624151 ↗

NCT06848764 ↗

NCT05447507 ↗

NCT00778063 ↗

NCT06473896 ↗

NCT07324057 ↗

NCT06784843 ↗

NCT03401606 ↗

NCT03143010 ↗

NCT01721460 ↗

NCT02064530 ↗

NCT03809182 ↗

NCT07538284 ↗

NCT03629483 ↗

NCT06620393 ↗

NCT02786212 ↗

NCT02099253 ↗

NCT04318158 ↗

NCT05991466 ↗

NCT00390871 ↗

NCT01169467 ↗

NCT07651488 ↗

NCT07462195 ↗

NCT03747432 ↗

NCT06502002 ↗

NCT05821972 ↗

NCT07493785 ↗

NCT02129426 ↗

NCT06312618 ↗

NCT07326332 ↗

NCT03262090 ↗

NCT03600506 ↗

NCT05300802 ↗

NCT04531371 ↗

NCT06203405 ↗

NCT03384563 ↗

NCT01200433 ↗

NCT07651956 ↗

NCT05661227 ↗

NCT03402113 ↗

NCT07411794 ↗

NCT06386770 ↗

NCT05674253 ↗

NCT07585201 ↗

NCT02675049 ↗

NCT04237792 ↗

NCT03658421 ↗

NCT04383418 ↗

NCT02384343 ↗

NCT06736496 ↗

NCT05991375 ↗

NCT03283150 ↗

NCT03325972 ↗

NCT02150759 ↗

NCT02612181 ↗

NCT02861716 ↗

NCT02993718 ↗

NCT06734195 ↗

NCT02896413 ↗

NCT05674877 ↗

NCT06386783 ↗

NCT05624866 ↗

NCT05274789 ↗

NCT06661980 ↗

NCT06958393 ↗

NCT02915042 ↗

NCT01665586 ↗

NCT06570187 ↗

NCT01920113 ↗

NCT07327372 ↗

NCT03551067 ↗

NCT01083797 ↗

NCT04785222 ↗

NCT05005715 ↗

NCT03317067 ↗

NCT02049970 ↗

NCT04661475 ↗

NCT02058485 ↗

NCT00853333 ↗

NCT07409935 ↗

NCT02386462 ↗

NCT05451381 ↗

NCT04916197 ↗

NCT03401736 ↗

NCT05902780 ↗

NCT02083055 ↗

NCT06207331 ↗

NCT01898819 ↗

NCT01565590 ↗

NCT06207344 ↗

NCT06702488 ↗

NCT07327879 ↗

NCT02185430 ↗

NCT03385967 ↗

NCT03938831 ↗

NCT02397603 ↗

NCT03938857 ↗

NCT00932386 ↗

NCT02375243 ↗

NCT04859283 ↗

NCT03030911 ↗

NCT02935933 ↗

NCT06208956 ↗

NCT06369103 ↗

NCT07168720 ↗

NCT06399185 ↗

NCT03030950 ↗

NCT02134327 ↗

NCT02633241 ↗

NCT07327931 ↗

NCT02874768 ↗

NCT05626998 ↗

NCT02787018 ↗

NCT06055101 ↗

NCT02781246 ↗

NCT07406555 ↗

NCT05719506 ↗

NCT07636070 ↗

NCT06210061 ↗

NCT04529187 ↗

NCT01886079 ↗

NCT01084473 ↗

NCT04858711 ↗

NCT02325882 ↗

NCT06662175 ↗

NCT07504497 ↗

NCT04529135 ↗

NCT02935959 ↗

NCT07622355 ↗

NCT04095754 ↗

NCT01344759 ↗

NCT06212401 ↗

NCT02903407 ↗

NCT06741566 ↗

NCT05718544 ↗

NCT00857727 ↗

NCT03276533 ↗

NCT05903963 ↗

NCT02604940 ↗

NCT06662318 ↗

NCT04675372 ↗

NCT03809442 ↗

NCT04331418 ↗

NCT00481312 ↗

NCT07271147 ↗

NCT01374737 ↗

NCT05163704 ↗

NCT07271459 ↗

NCT04526652 ↗

NCT05323214 ↗

NCT01572454 ↗

NCT07279727 ↗

NCT03629262 ↗

NCT07329933 ↗

NCT07326397 ↗

NCT02927379 ↗

NCT02284243 ↗

NCT05111431 ↗

NCT04981951 ↗

NCT03115047 ↗

NCT05369468 ↗

NCT02252523 ↗

NCT02299232 ↗

NCT04106999 ↗

NCT03102359 ↗

NCT02727621 ↗

NCT05323565 ↗

NCT05718024 ↗

NCT06215768 ↗

NCT05500703 ↗

NCT07542990 ↗

NCT02707809 ↗

NCT07057739 ↗

NCT02394418 ↗

NCT07597109 ↗

NCT05718011 ↗

NCT06789016 ↗

NCT05291221 ↗

NCT06392321 ↗

NCT03524950 ↗

NCT01722409 ↗

NCT03284307 ↗

NCT04528173 ↗

NCT02299063 ↗

NCT02612363 ↗

NCT03512574 ↗

NCT06545890 ↗

NCT04237532 ↗

NCT06581731 ↗

NCT06897696 ↗

NCT01733043 ↗

NCT05851768 ↗

NCT06824077 ↗

NCT06305221 ↗

NCT04358367 ↗

NCT06218797 ↗

NCT02607163 ↗

NCT06789393 ↗

NCT05500261 ↗

NCT03925779 ↗

NCT04263844 ↗

NCT07330375 ↗

NCT07239479 ↗

NCT07064720 ↗

NCT03327389 ↗

NCT06304909 ↗

NCT04700228 ↗

NCT07610343 ↗

NCT07330999 ↗

NCT02142595 ↗

NCT07398066 ↗

NCT06304324 ↗

NCT06685081 ↗

NCT00460473 ↗

NCT05057689 ↗

NCT05534230 ↗

NCT07544173 ↗

NCT04700514 ↗

NCT02886429 ↗

NCT03622047 ↗

NCT05045170 ↗

NCT05950646 ↗

NCT00671931 ↗

NCT04307290 ↗

NCT02123355 ↗

NCT05631028 ↗

NCT02952222 ↗

NCT03596775 ↗

NCT01791296 ↗

NCT02773017 ↗

NCT04662177 ↗

NCT00349245 ↗

NCT03151668 ↗

NCT03172065 ↗

NCT06835010 ↗

NCT04029467 ↗

NCT02582372 ↗

NCT02137863 ↗

NCT02072083 ↗

NCT04105946 ↗

NCT01617694 ↗

NCT02409810 ↗

NCT04827056 ↗

NCT05659212 ↗

NCT07657715 ↗

NCT05462938 ↗

NCT02823977 ↗

NCT05451121 ↗

NCT03778671 ↗

NCT05072704 ↗

NCT02616523 ↗

NCT06958367 ↗

NCT07332130 ↗

NCT02537249 ↗

NCT07300826 ↗

NCT04289142 ↗

NCT02237495 ↗

NCT06712186 ↗

NCT01774305 ↗

NCT03640390 ↗

NCT03719001 ↗

NCT06743919 ↗

NCT07580768 ↗

NCT03091166 ↗

NCT04659642 ↗

NCT06690021 ↗

NCT02490072 ↗

NCT03655847 ↗

NCT03622502 ↗

NCT04073758 ↗

NCT06133712 ↗

NCT01895023 ↗

NCT01918917 ↗

NCT04525274 ↗

NCT04753515 ↗

NCT07101367 ↗

NCT01557270 ↗

NCT06993194 ↗

NCT05324891 ↗

NCT04791059 ↗

NCT07392983 ↗

NCT02777619 ↗

NCT06631625 ↗

NCT02652507 ↗

NCT04096768 ↗

NCT03940469 ↗

NCT01076790 ↗

NCT05110339 ↗

NCT02833688 ↗

NCT06631534 ↗

NCT05880693 ↗

NCT05860010 ↗

NCT07705022 ↗

NCT07392177 ↗

NCT03143972 ↗

NCT06614881 ↗

NCT02902380 ↗

NCT04089592 ↗

NCT03809923 ↗

NCT03522688 ↗

NCT07332572 ↗

NCT07677917 ↗

NCT06867302 ↗

NCT02170948 ↗

NCT03513757 ↗

NCT01956981 ↗

NCT03477344 ↗

NCT04470050 ↗

NCT03960775 ↗

NCT03805945 ↗

NCT01365923 ↗

NCT02961361 ↗

NCT02261675 ↗

NCT02250820 ↗

NCT03399019 ↗

NCT04226885 ↗

NCT00608231 ↗

NCT03399838 ↗

NCT04266145 ↗

NCT06470100 ↗

NCT06229054 ↗

NCT03312413 ↗

NCT07073846 ↗

NCT06370442 ↗

NCT03436472 ↗

NCT05634148 ↗

NCT06052111 ↗

NCT02353182 ↗

NCT00808665 ↗

NCT06665438 ↗

NCT02476981 ↗

NCT00875550 ↗

NCT03164590 ↗

NCT02524145 ↗

NCT02836431 ↗

NCT02327156 ↗

NCT06695468 ↗

NCT07056582 ↗

NCT02809937 ↗

NCT04266340 ↗

NCT05579964 ↗

NCT00786370 ↗

NCT06527976 ↗

NCT07145697 ↗

NCT05226325 ↗

NCT03844841 ↗

NCT03708315 ↗

NCT04266665 ↗

NCT02154074 ↗

NCT02720705 ↗

NCT05840328 ↗

NCT04356638 ↗

NCT07056244 ↗

NCT04006054 ↗

NCT07231926 ↗

NCT02208505 ↗

NCT03064633 ↗

NCT07263165 ↗

NCT05225610 ↗

NCT05327088 ↗

NCT02929095 ↗

NCT01076816 ↗

NCT02540070 ↗

NCT03775876 ↗

NCT07047898 ↗

NCT04628663 ↗

NCT04720963 ↗

NCT02472522 ↗

NCT06231979 ↗

NCT06103721 ↗

NCT07389096 ↗

NCT03668951 ↗

NCT07549282 ↗

NCT02416063 ↗

NCT02780427 ↗

NCT07048873 ↗

NCT04426552 ↗

NCT04135014 ↗

NCT01789385 ↗

NCT01017237 ↗

NCT02089932 ↗

NCT06470854 ↗

NCT00318955 ↗

NCT01381627 ↗

NCT05951387 ↗

NCT06233032 ↗

NCT07470775 ↗

NCT02552459 ↗

NCT06233565 ↗

NCT06233604 ↗

NCT06837818 ↗

NCT06555458 ↗

NCT06014359 ↗

NCT03399474 ↗

NCT06879496 ↗

NCT02715154 ↗

NCT03477994 ↗

NCT06233617 ↗

NCT01065701 ↗

NCT01535287 ↗

NCT05003102 ↗

NCT07579806 ↗

NCT01833819 ↗

NCT06667024 ↗

NCT02141412 ↗

NCT03328299 ↗

NCT07388251 ↗

NCT01072643 ↗

NCT02220361 ↗

NCT06993740 ↗

NCT07677215 ↗

NCT03588988 ↗

NCT07145775 ↗

NCT01736020 ↗

NCT02512809 ↗

NCT04949477 ↗

NCT03466632 ↗

NCT02253199 ↗

NCT02013570 ↗

NCT06235606 ↗

NCT06356415 ↗

NCT07386600 ↗

NCT06490731 ↗

NCT02454881 ↗

NCT03570645 ↗

NCT03690622 ↗

NCT02548923 ↗

NCT07385898 ↗

NCT03251651 ↗

NCT07149545 ↗

NCT01687751 ↗

NCT01979653 ↗

NCT04399343 ↗

NCT03151863 ↗

NCT02878707 ↗

NCT04268303 ↗

NCT06300099 ↗

NCT06951256 ↗

NCT04142840 ↗

NCT00573066 ↗

NCT00526760 ↗

NCT07385352 ↗

NCT07676955 ↗

NCT04628559 ↗

NCT03877120 ↗

NCT06859892 ↗

NCT05279898 ↗

NCT07385040 ↗

NCT02510612 ↗

NCT03613558 ↗

NCT03412474 ↗

NCT05280223 ↗

NCT06238011 ↗

NCT04659057 ↗

NCT04923737 ↗

NCT00921284 ↗

NCT07550881 ↗

NCT03933306 ↗

NCT05919732 ↗

NCT04270708 ↗

NCT05767827 ↗

NCT04718714 ↗

NCT07121764 ↗

NCT03139279 ↗

NCT05325762 ↗

NCT01687868 ↗

NCT07105618 ↗

NCT05705128 ↗

NCT03596424 ↗

NCT07699523 ↗

NCT06046105 ↗

NCT06096181 ↗

NCT04658732 ↗

NCT03251222 ↗

NCT04798482 ↗

NCT02122510 ↗

NCT00142493 ↗

NCT02853864 ↗

NCT07072650 ↗

NCT03012984 ↗

NCT01045122 ↗

NCT02638545 ↗

NCT06566482 ↗

NCT01151865 ↗

NCT01152021 ↗

NCT02035930 ↗

NCT06946212 ↗

NCT06884540 ↗

NCT03293927 ↗

NCT03060070 ↗

NCT01224470 ↗

NCT04971759 ↗

NCT02026141 ↗

NCT06952309 ↗

NCT02958150 ↗

NCT03131375 ↗

NCT06490614 ↗

NCT05988671 ↗

NCT07337135 ↗

NCT02575521 ↗

NCT07204106 ↗

NCT06521697 ↗

NCT06614010 ↗

NCT07502651 ↗

NCT04300985 ↗

NCT03012971 ↗

NCT03337672 ↗

NCT02155010 ↗

NCT04398589 ↗

NCT03275207 ↗

NCT03388541 ↗

NCT06453681 ↗

NCT06566469 ↗

NCT05657028 ↗

NCT01512355 ↗

NCT00936377 ↗

NCT06853431 ↗

NCT06403670 ↗

NCT06128356 ↗

NCT05979558 ↗

NCT05703048 ↗

NCT04919174 ↗

NCT01256866 ↗

NCT02275182 ↗

NCT03438240 ↗

NCT07299877 ↗

NCT02658760 ↗

NCT05849597 ↗

NCT04824144 ↗

NCT03647579 ↗

NCT07678216 ↗

NCT04801589 ↗

NCT06378827 ↗

NCT05218161 ↗

NCT07377981 ↗

NCT03293277 ↗

NCT06355960 ↗

NCT05577871 ↗

NCT07289620 ↗

NCT04876937 ↗

NCT05013320 ↗

NCT03211871 ↗

NCT05431322 ↗

NCT03926663 ↗

NCT03799783 ↗

NCT04391361 ↗

NCT06970626 ↗

NCT02062333 ↗

NCT04062123 ↗

NCT06863064 ↗

NCT06970678 ↗

NCT04935541 ↗

NCT04715165 ↗

NCT01353378 ↗

NCT07255027 ↗

NCT03714919 ↗

NCT01976754 ↗

NCT01353456 ↗

NCT06860100 ↗

NCT07050212 ↗

NCT05952050 ↗

NCT05681429 ↗

NCT05681572 ↗

NCT02393066 ↗

NCT00226785 ↗

NCT06389318 ↗

NCT02488473 ↗

NCT03984240 ↗

NCT07675616 ↗

NCT00334360 ↗

NCT04007341 ↗

NCT07051512 ↗

NCT07145814 ↗

NCT04508166 ↗

NCT00576381 ↗

NCT06371638 ↗

NCT01725607 ↗

NCT02358057 ↗

NCT04822064 ↗

NCT02854904 ↗

NCT06651905 ↗

NCT06354673 ↗

NCT02282787 ↗

NCT06354478 ↗

NCT06668220 ↗

NCT03793751 ↗

NCT00494832 ↗

NCT03775655 ↗

NCT05216055 ↗

NCT03375385 ↗

NCT02122055 ↗

NCT05639777 ↗

NCT02109965 ↗

NCT03046238 ↗

NCT05640427 ↗

NCT05640453 ↗

NCT00697788 ↗

NCT03355534 ↗

NCT07501728 ↗

NCT01889004 ↗

NCT01837290 ↗

NCT02535273 ↗

NCT06502262 ↗

NCT05640479 ↗

NCT01179438 ↗

NCT05215158 ↗

NCT03756961 ↗

NCT07475156 ↗

NCT06251375 ↗

NCT00338546 ↗

NCT05809518 ↗

NCT07555821 ↗

NCT01845441 ↗

NCT07290595 ↗

NCT05636566 ↗

NCT07238101 ↗

NCT06823349 ↗

NCT04397406 ↗

NCT06252662 ↗

NCT02096068 ↗

NCT05288738 ↗

NCT00744380 ↗

NCT03624595 ↗

NCT01964586 ↗

NCT05641064 ↗

NCT02244515 ↗

NCT07497009 ↗

NCT07556133 ↗

NCT07154849 ↗

NCT05778305 ↗

NCT07556523 ↗

NCT00505804 ↗

NCT05335655 ↗

NCT06253260 ↗

NCT03480061 ↗

NCT02652312 ↗

NCT05577260 ↗

NCT02619513 ↗

NCT03600727 ↗

NCT02053766 ↗

NCT07369128 ↗

NCT01524367 ↗

NCT07557576 ↗

NCT05700045 ↗

NCT07176065 ↗

NCT07072117 ↗

NCT03156296 ↗

NCT03370588 ↗

NCT02866409 ↗

NCT04285255 ↗

NCT05919173 ↗

NCT02741219 ↗

NCT01474213 ↗

NCT05337085 ↗

NCT06624319 ↗

NCT03912740 ↗

NCT02066727 ↗

NCT04320589 ↗

NCT04928391 ↗

NCT04656470 ↗

NCT07501221 ↗

NCT02641938 ↗

NCT07368075 ↗

NCT06017167 ↗

NCT05577117 ↗

NCT01378988 ↗

NCT07298525 ↗

NCT07557680 ↗

NCT04350086 ↗

NCT01314209 ↗

NCT01378741 ↗

NCT07340008 ↗

NCT01688648 ↗

NCT02843698 ↗

NCT04928300 ↗

NCT04138472 ↗

NCT07066605 ↗

NCT02435537 ↗

NCT05766436 ↗

NCT07254936 ↗

NCT00837187 ↗

NCT02810899 ↗

NCT03370562 ↗

NCT06979791 ↗

NCT05813106 ↗

NCT03069638 ↗

NCT03172897 ↗

NCT03337581 ↗

NCT02856594 ↗

NCT02455609 ↗

NCT03456661 ↗

NCT02270281 ↗

NCT07365800 ↗

NCT03480607 ↗

NCT01652586 ↗

NCT03076099 ↗

NCT05641376 ↗

NCT07695220 ↗

NCT03817112 ↗

NCT06418308 ↗

NCT00464451 ↗

NCT02163980 ↗

NCT06994273 ↗

NCT03078946 ↗

NCT06864416 ↗

NCT07180940 ↗

NCT06352593 ↗

NCT03222323 ↗

NCT05349448 ↗

NCT03480789 ↗

NCT06125665 ↗

NCT06098209 ↗

NCT05698407 ↗

NCT07140627 ↗

NCT05965895 ↗

NCT05837000 ↗

NCT03143244 ↗

NCT00464490 ↗

NCT07669012 ↗

NCT02157818 ↗

NCT06037135 ↗

NCT03742180 ↗

NCT01785446 ↗

NCT06018948 ↗

NCT04820205 ↗

NCT01857141 ↗

NCT01606852 ↗

NCT03983915 ↗

NCT03983889 ↗

NCT02985697 ↗

NCT03355053 ↗

NCT02660658 ↗

NCT06654531 ↗

NCT01748630 ↗

NCT04820101 ↗

NCT02768688 ↗

NCT03933280 ↗

NCT06259565 ↗

NCT04304157 ↗

NCT02492269 ↗

NCT06607861 ↗

NCT07292324 ↗

NCT06907277 ↗

NCT04174872 ↗

NCT02382432 ↗

NCT03108937 ↗

NCT06573957 ↗

NCT05435560 ↗

NCT01513772 ↗

NCT06414941 ↗

NCT07363681 ↗

NCT02007798 ↗

NCT03290625 ↗

NCT03170739 ↗

NCT03236727 ↗

NCT03735368 ↗

NCT07094165 ↗

NCT04516174 ↗

NCT07202624 ↗

NCT05283083 ↗

NCT05481281 ↗

NCT03391609 ↗

NCT04284150 ↗

NCT07573969 ↗

NCT00401206 ↗

NCT01404689 ↗

NCT01159262 ↗

NCT01915277 ↗

NCT04508894 ↗

NCT02776189 ↗

NCT04748224 ↗

NCT04042727 ↗

NCT01578161 ↗

NCT02224443 ↗

NCT04391855 ↗

NCT06778811 ↗

NCT05436964 ↗

NCT01578174 ↗

NCT04878510 ↗

NCT03422978 ↗

NCT05376761 ↗

NCT02117726 ↗

NCT05283408 ↗

NCT06264739 ↗

NCT02393677 ↗

NCT06020781 ↗

NCT04973124 ↗

NCT05688345 ↗

NCT00464763 ↗

NCT05814744 ↗

NCT04906889 ↗

NCT07103616 ↗

NCT07479602 ↗

NCT01973452 ↗

NCT01840254 ↗

NCT02724098 ↗

NCT00652028 ↗

NCT02187068 ↗

NCT03529643 ↗

NCT02405689 ↗

NCT06837519 ↗

NCT03109990 ↗

NCT06613243 ↗

NCT02966743 ↗

NCT02296073 ↗

NCT04597268 ↗

NCT04394481 ↗

NCT06466915 ↗

NCT05340803 ↗

NCT02549768 ↗

NCT04906772 ↗

NCT05192629 ↗

NCT07564037 ↗

NCT06838650 ↗

NCT07485127 ↗

NCT00826553 ↗

NCT04234906 ↗

NCT02550795 ↗

NCT01362205 ↗

NCT07343843 ↗

NCT02982512 ↗

NCT03054857 ↗

NCT01528891 ↗

NCT05909215 ↗

NCT04276883 ↗

NCT03091894 ↗

NCT02316236 ↗

NCT04910477 ↗

NCT02550782 ↗

NCT07671066 ↗

NCT03234660 ↗

NCT05692167 ↗

NCT07565116 ↗

NCT06671327 ↗

NCT04171349 ↗

NCT01158820 ↗

NCT06030804 ↗

NCT04818749 ↗

NCT02559102 ↗

NCT03762785 ↗

NCT05850455 ↗

NCT07565662 ↗

NCT05375188 ↗

NCT01691001 ↗

NCT05342376 ↗

NCT02557867 ↗

NCT00363935 ↗

NCT01963546 ↗

NCT05572723 ↗

NCT06979141 ↗

NCT06974656 ↗

NCT07190612 ↗

NCT05984212 ↗

NCT01377623 ↗

NCT05911776 ↗

NCT04509414 ↗

NCT05351489 ↗

NCT05439005 ↗

NCT05342844 ↗

NCT06274333 ↗

NCT02888275 ↗

NCT02108171 ↗

NCT06822088 ↗

NCT05347173 ↗

NCT02566863 ↗

NCT01438957 ↗

NCT07355049 ↗

NCT07180810 ↗

NCT03390972 ↗

NCT05342870 ↗

NCT01283412 ↗

NCT02169843 ↗

NCT05775861 ↗

NCT03174678 ↗

NCT06022614 ↗

NCT02197403 ↗

NCT04747171 ↗

NCT03612440 ↗

NCT07174440 ↗

NCT00335972 ↗

NCT00691886 ↗

NCT02330120 ↗

NCT02239445 ↗

NCT05158348 ↗

NCT04976374 ↗

NCT01895348 ↗

NCT04282239 ↗

NCT03289325 ↗

NCT06837844 ↗

NCT04813016 ↗

NCT06283836 ↗

NCT03434366 ↗

NCT04941508 ↗

NCT04877639 ↗

NCT02714725 ↗

NCT07567495 ↗

NCT05194904 ↗

NCT04940689 ↗

NCT03451227 ↗

NCT05195034 ↗

NCT02213159 ↗

NCT05439564 ↗

NCT07345715 ↗

NCT05567523 ↗

NCT07276906 ↗

NCT03468062 ↗

NCT03632161 ↗

NCT05892705 ↗

NCT04704622 ↗

NCT05654064 ↗

NCT02109510 ↗

NCT07570160 ↗

NCT06985290 ↗

NCT03805568 ↗

NCT03757897 ↗

NCT03120442 ↗

NCT06684197 ↗

NCT04027829 ↗

NCT07350928 ↗

NCT02475824 ↗

NCT02634021 ↗

NCT01485380 ↗

NCT02250703 ↗

NCT03077503 ↗

NCT01739933 ↗

NCT04815265 ↗

NCT02730845 ↗

NCT03585452 ↗

NCT04816162 ↗

NCT04382170 ↗

NCT05574179 ↗

NCT06579001 ↗

NCT05345574 ↗

NCT04652661 ↗

NCT04642651 ↗

NCT07601698 ↗

NCT07054138 ↗

NCT07568873 ↗

NCT05688371 ↗

NCT03927963 ↗

NCT02648958 ↗

NCT07569614 ↗

NCT02766556 ↗

NCT05689242 ↗

NCT03265470 ↗

NCT04706897 ↗

NCT01964040 ↗

NCT03957304 ↗

NCT02528513 ↗

NCT06414395 ↗

NCT06535256 ↗

NCT07244822 ↗

NCT07350668 ↗

NCT04706767 ↗

NCT05197439 ↗

NCT03466242 ↗

NCT03120247 ↗

NCT07569536 ↗

NCT02793986 ↗

NCT06281561 ↗

NCT02529202 ↗

NCT03813277 ↗

NCT02044224 ↗

NCT04817033 ↗

NCT06346561 ↗

NCT06281977 ↗

NCT04652427 ↗

NCT00852046 ↗

NCT07482540 ↗

NCT03632460 ↗

NCT04484922 ↗

NCT02820610 ↗

NCT01485393 ↗

NCT03120234 ↗
Known as (+)-4-(S)-\[1-(2,3-dimethylphenyl ) ethyl\]-1H-imidazole hydrochloride “Background Information: Dexmedetomidine is an α-adrenoceptor agonist, and its chemical name is (+)-4-(S)-\[1-(2,3-dimethylphenyl ) ethyl\]-1H-imidazole hydrochloride.” NCT02007798 ↗
Known as Ai Beining “Dexmedetomidine was developed by the Orion Pharma (Finland) Corporation and Abott (USA), and introduced to China in 2009 (trade name: Ai Beining).” NCT02007798 ↗
Known as BXCL501 “Subjects will be given a sublingual formulation of BXCL501 (dexmedetomidine)” NCT03708315 ↗
13

“Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 40µg” NCT06335407 ↗

“Sublingual film containing dexmedetomidine (BXCL501)” NCT04268303 ↗

“Sublingual film containing Dexmedetomidine (BXCL501)” NCT04276883 ↗

“Sublingual film containing dexmedetomidine (BXCL501)” NCT05974527 ↗

NCT07116694 ↗

NCT05665088 ↗

NCT05271552 ↗

NCT05313386 ↗

NCT05025605 ↗

NCT05276830 ↗

NCT05658510 ↗

NCT05712707 ↗

NCT04010305 ↗
Known as DA-9501 “The purpose of this study is to examine the efficacy and safety of DA-9501 (Dexmedetomidine) in patients who require sedation during the surgery that requires epidural or...” NCT01438957 ↗
Known as deksmedetomidine “One commonly used sedative drug is deksmedetomidine, an α2 receptor agonist.” NCT03601091 ↗
1

NCT02104297 ↗
Known as DEM “perineural dexamethasone (DEX) versus dexmedetomidine (DEM) when used as adjuvants to ropivacaine in pediatric popliteal sciatic nerve blocks” PMID 41043950 ↗ Oct 2025
Known as DEX “After surgery, patient-controlled intravenous analgesia will be established with dexmedetomidine (DEX 1.5 ug/ml), esketamine (ESK 0.5 mg/ml), and sufentanil (1.25 ug/ml),...” NCT07523321 ↗
102

“Dexmedetomidine (Dex) is a new type of highly selective α2-adrenergic receptor agonist, which has the effects of sedative-hypnotic, anti-inflammatory, stress reduction,...” NCT06207331 ↗

“BACKGROUND: Desaturation is a common complication of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). Dexmedetomidine (DEX), a commonly used...” PMID 33122573 ↗ May 2021

“Dexmedetomidine (DEX) is a centrally acting alpha-2-adrenoceptor agonist that has potential in the management of alcohol withdrawal syndrome (AWS) owing to its ability to...” PMID 26525052 ↗ Nov 2015

“The goal is to determine if the propofol (PR) (sedative agent), dexmedetomidine (DEX)(selective α2-adrenergic receptor (α2-AR) agonist) or their combination could improve and...” NCT05450497 ↗

“Dexmedetomidine (Dex) is an α2-adrenergic agonist sedative commonly used in invasive mechanical ventilation (IMV) that promotes patient wakefulness, has no effect on...” NCT06259565 ↗

“Following Anesthesia induction, dexmedetomidine (DEX) Low Dose group received a DEX loading dose (0.5 µg/kg over 10 min), followed by continuous infusions of 0.3 µg/kg/h,...” NCT07145814 ↗

“A randomized double-blind controlled trial was conducted to investigate whether the administration of DEX, immediately after delivery and for patient-controlled intravenous...” PMID 32210537 ↗ Mar 2020

“Dexmedetomidine (DEX), a sedative commonly used in EVT, can stabilize hemodynamics by inhibiting the sympathetic nervous system and alleviate ischemia-reperfusion injury...” PMID 38439027 ↗ Mar 2024

“This study aims to evaluate the effect of intranasal dexmedetomidine (Dex) administered before combined spinal-epidural labor analgesia on the incidence of postpartum...” NCT07501728 ↗

“Research focuses on the role of intravenous (IV) nefopam, dexmedetomidine (DEX), and meperidine in averting shivering episodes in adult individuals receiving SA for surgical...” PMID 41346412 ↗ Dec 2025

“BACKGROUND: To determine whether continuous intravenous infusion of dexmedetomidine (DEX) can affect the incidence of Emergence Agitation (EA) after general anesthesia in...” PMID 26464000 ↗ Oct 2015

“Dexmedetomidine (DEX) a potent α 2 agonist that have unique analgesic, anxiolytic and sedative profile has been called upon as attractive adjunct in general as well as regional...” NCT04304157 ↗

“We hypothesized that the intraoperative administration of dexmedetomidine (DEX), a sympatholytic agent, would reduce the stress response and improve the quality of recovery in...” PMID 22824921 ↗ Jan 2013

“PURPOSE: To compare dexmedetomidine (DEX) with standard care (SC, either propofol or midazolam) for long-term sedation in terms of maintaining target sedation and length of...” PMID 18795253 ↗ Sep 2008

“This meta-analysis aimed to systematically collect the current evidence regarding the efficacy and safety of dexmedetomidine (DEX) as an anesthetic adjuvant for patients...” PMID 24974190 ↗ Jun 2014

“Dexmedetomidine (DEX), a highly selective α2-adrenoreceptor agonist, is a centrally acting non-opioid agent increasingly utilized in clinical practice for its antinociceptive...” NCT07389096 ↗

“who were randomised to receive either dexmedetomidine sedation (DEX) with caudal block or general sevoflurane anaesthesia with tracheal intubation and caudal block (GA) for...” PMID 30916007 ↗ Mar 2019

“Dexmedetomidine (DEX) is increasingly being used as a sedative for monitored anesthesia care (MAC) because of its analgesic properties, "cooperative sedation," and lack of...” PMID 19713256 ↗ Aug 2009

“STUDY OBJECTIVES: To assess the effect of dexmedetomidine (DEX) on postoperative sleep quality using polysomnography (PSG) to identify possible interventions for postoperative...” PMID 36944937 ↗ Mar 2023

“The aim of this study was to evaluate the efficacy of remifentanil (REM) versus dexmedetomidine (DEX) for treatment of cardiac surgery (CS) patients with moderate to severe NIV...” PMID 33209418 ↗ Oct 2020

“Dexmedetomidine (Dex) is a highly selective centrally acting α2-adrenoreceptor agonist that produces cooperative sedation, anxiolysis, and analgesia with minimal respiratory depression.” NCT04327726 ↗

“Dexmedetomidine (DEX) is a highly selective alpha2 adrenoceptor agonist with broad pharmacological effects, including sedation, analgesia, anxiolysis, and sympathetic tone inhibition.” PMID 31668347 ↗ Oct 2019

“This prospective, randomized, double-blind, placebo-controlled study evaluated the effect of dexmedetomidine (DEX) for reducing the incidence and severity of propofol injection pain.” PMID 25342205 ↗ Oct 2014

“Dexmedetomidine (DEX), a highly selective alpha-2 receptor agonist, is increasingly used in anesthesia with sedative, hypnotic, anxiolytic, sympatholytic, and analgesic effects.” NCT05863416 ↗

“The aim of the study was to evaluate safety and efficacy of melatonin (Mel) and dexmedetomidine (Dex; intranasal and sublingual application) for sleep induction prior to EEG.” PMID 38725985 ↗ Apr 2024

“Dexmedetomidine (D) group, where Dex. (Precedex, hospira, Egypt) 0.8 μg/kg was given intravenously over 10 min as a loading dose, and then infused at a rate of 0.4 μg/kg/h;” NCT05271253 ↗

“The medication in question (dexmedetomidine, DEX) has been proven to be a safe and reliable sedative in different settings even though its use is off-label in pediatrics.” NCT03399838 ↗

“After surgery, patient-controlled intravenous analgesia will be established with dexmedetomidine (DEX 1.5 ug/ml), esketamine (ESK 0.5 mg/ml), and sufentanil (1.25 ug/ml)” NCT07525999 ↗

“The purpose of this study was to compare the perioperative effects of the intramuscular (i.m.) alpha 2 agonist, dexmedetomidine (DEX), and midazolam (MID) premedication.” PMID 7943770 ↗ Oct 1994

“Dexmedetomidine (DEX) α-2 adrenergic receptor consists of three α-2 isoreceptors (α-2a, α-2b and α-2c), which regulate the various pharmacodynamic effects of this drug .” NCT04838379 ↗

“We evaluated bilateral ultrasound (US)-guided single shot erector spinae plane (ESP) block at the level of lumbar 3 (L3) vertebra with or without dexmedetomidine (Dex).” NCT03746418 ↗

“Recently we have introduced Intra-nasal Dexmedetomidine (IN DEX), with an initial impression of much improved drug acceptance and possibly improved efficacy over TFS.” NCT04270708 ↗

“Postoperative delirium can significantly reduce the short-term and long-term quality of life in elderly patients, which can be alleviated by dexmedetomidine (DEX).” PMID 37433729 ↗ Jul 2023

“This study evaluated dexmedetomidine (DEX) on NGF, BDNF, GDNF, and EPI in severe alcohol withdrawal and related their plasma concentrations to DEX concentrations.” PMID 25638740 ↗ Jan 2015

“Dexmedetomidine (Dex) activates the α2 adrenergic receptor that is present within the locus coeruleus, leading to anxiolysis, hypnosis, analgesia, and sedation.” NCT06186895 ↗

“Patients were randomized to receive sufentanil 0.05ug/kh/h + dexmedetomidine 0.1ug/kg/h (DEX group) or sufentanil 0.05ug/kg/h + saline (control group) for 48h.” NCT03117023 ↗

“OBJECTIVE: We attempted to manage the systematic review and a meta-analysis to clarify the efficacy of dexmedetomidine (DEX) in potential prevention on CRBD.” PMID 34967355 ↗ Dec 2021

“Dexmedetomidine (Dex), a highly selective α2-adrenergic receptor agonist, is widely used for sedation and analgesia in the ICU or as an anesthetic adjuvant.” NCT05577871 ↗

“Dexmedetomidine (DEX) has sympatholytic, sedative, analgesic, and anxiolytic effects that attenuate the catecholamine response to perioperative stress.” NCT00398827 ↗

“Dexmedetomidine (DEX), a highly potent and selective α2-adrenoceptors (α2R) agonist used in clinical practice for sedation, analgesia, and anxiolysis” NCT04289142 ↗

“Dexmedetomidine (DEX), a selective agonist of α2-adrenergic receptors, can be an effective adjuvant to local anesthetics for peripheral nerve block.” NCT02766556 ↗

“Administration of dexmedetomidine (DEX) in the pediatric population for its sedative, analgesic, and anxiolytic properties has been widely reported” PMID 26332857 ↗ Nov 2015

“Dexmedetomidine (DEX). DEX, (S)-4-\[1-(2,3 dimethylphenyl)ethyl\]-3H-imidazole\], is a selective and potent α2-adrenergic receptor (α2-AR) agonist” NCT04661475 ↗

“Dexmedetomidine(DEX) could provide dose-dependent sedation , analgesia , anti-anxiety and inhibition of sympathetic nerves and other effects.” NCT02773017 ↗

“Studies showed dexmedetomidine (DEX) could improve surgical field, but the effect for functional nasal endoscopic surgery (FESS) was unclear.” NCT04276545 ↗

“Dexmedetomidine (DEX) has been shown to provide good perioperative haemodynamic stability with decreased intraoperative opioid requirements.” PMID 16914460 ↗ Aug 2006

“Dexmetedomidine (DEX) is a recent more selective α2 adrenergic agonist that has been used successfully during IVRA at a dose of 0.5µg/kg.” NCT05342870 ↗

“Dexmedetomidine (DEX) is a highly selective a2-agonist with sedative and analgesic effects and reduces sympathetic response to stimuli.” NCT03588988 ↗

“One potential treatment is dexmedetomidine (DEX), a highly selective α 2-adrenoreceptor agonist that is used as an anesthetic adjuvant.” PMID 32317860 ↗ Apr 2020

“The alpha-2 agonist dexmedetomidine (dex) has been approved for short-term sedation in surgical intensive care unit (ICU) patients.” NCT00641563 ↗

“Many studies have shown that dexmedetomidine (DEX) reduced the incidence of delirium after non-cardiac surgery in elderly patients.” PMID 36690404 ↗ Jan 2023

“This study evaluated the effectiveness of dexmedetomidine (Dex) and Ketamine as adjuvants in EOIPB for post-thoracotomy pain (PTP).” PMID 41299290 ↗ Nov 2025

“So, to overcome this flaw some adjuvants were proven to prolong the analgesia duration as Dexmetedomidine (Dex), and magnesium.” NCT04498351 ↗

“Dexmedetomidine (Dex) is a novel α2-adrenoceptor agonist that is primarily used in surgical anesthesia and conscious-sedation.” NCT02842437 ↗

“This research study is examining the absorption of the sedative dexmedetomidine (DEX) in the blood when given by nasal spray.” NCT02836431 ↗

“BACKGROUND: Buccal dexmedetomidine (DEX) produces adequate preoperative sedation and anxiolysis when used as a premedication.” PMID 32889844 ↗ Feb 2021

“Dexmedetomidine (DEX) has sedative, sympatholytic and analgesic effects and might be beneficial if used as an adjuvant” PMID 29678158 ↗ Apr 2018

“Dexmedetomidine (DEX) was administered during anesthesia and early postoperative period for patients in the DEX group” PMID 28182690 ↗ Feb 2017

“Dexmedetomidine (DEX) is a highly selective agonist that acts by binding with presynaptic alpha 2-adrenergic receptor” NCT06910644 ↗

“Dexmedetomidine (Dex) is a highly selective 2-adrenergic receptor agonist with significant analgesia affection.” NCT05500703 ↗

“Animal data have shown that dexmedetomidine (DEX) induces neuroprotective effects only at well-adjusted doses.” NCT05369949 ↗

“Dexmedetomidine (DEX) is known as a type of alpha agonist which can elongate the duration of regional block.” NCT04398589 ↗

“An alternative TIVA that is very commonly used for adult spine surgery is propofol + dexmedetomidine (DEX).” NCT06096181 ↗

“Dexmedetomidine (DEX), a selective alpha-2 agonist, has sympatholytic, sedative, and analgesic properties.” NCT02097407 ↗

“Its active molecule, Dexmedetomidine (Dex) is a selective and powerful agonist of α2-adrenoreceptors (AR).” NCT03151863 ↗

“The α2-adrenergic agonist dexmedetomidine (DEX) is a sedative and can be used as an adjunct to hypnotics.” PMID 32334510 ↗ Apr 2020

“Dexmedetomidine (DEX) is a selectiveα2 adrenergic receptor agonist with sedative and analgesic effects.” NCT07125573 ↗

“DEXMEDETOMIDINE (DEX), an alpha-2 adrenoreceptor agonist, is gaining popularity in neuroanesthesia.” NCT00335972 ↗

“Dex (Precedex, Dexmedetomidine HCl Injection) is produced by Pfizer Inc, NY, Ny (formerly Hospira).” NCT03355053 ↗

“Dexmedetomidine (Dex) is a selective α-2 adrenoreceptor agonist that can alleviate lung injury.” PMID 36166132 ↗ Sep 2022

“Dexmedetomidine (Dex) administration perioperatively might help to reduce the incidence of POD.” PMID 37743486 ↗ Sep 2023

“Dexmeditomidine (DEX) has been studied as adjuvant for nerve block to aumnet the pain reliefe.” NCT05624866 ↗

“Dexmedetomidine (DEX) is a specific alpha2 adrenergic agonist with promising data in NICU.” NCT07241351 ↗

“Dexmedetomidine (DEX), is a selective centrally acting α 2-adrenergic receptors agonist” NCT04709315 ↗

“Dexmedetomidine(Dex) is the only anesthetic which has sedative and analgesic effects.” NCT03095469 ↗

“Dexmedetomidine (DEX) sedation is widely used in deep brain stimulation implantation” NCT05376761 ↗

“Dexmedetomidine (Dex), a potent and highly selective α2-adrenergic receptor agonist” NCT06838650 ↗

“Dexmedetomidine(DEX) is a novel , highly selective α2 adrenergic receptor agonists” NCT02099253 ↗

“Dexmedetomidine (DEX), is a highly selective alpha2 adrenoceptor (α2-AR) agonist” PMID 35291989 ↗ Mar 2022

“Dexmedetomidine (DEX) offers non-opioid analgesia and opioid-sparing effects.” PMID 42207991 ↗ May 2026

“Dexmedetomidine (DEX) is a highly selective α-2 adrenergic receptor agonist.” NCT06352593 ↗

“Dexmedetomidine (Dex) is a highly selective α 2-adrenergic receptor agonist” NCT06619912 ↗

“Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 40µg” NCT06335407 ↗

“administration of dexmedetomidine (DEX) can prolong analgesic duration.” PMID 26133711 ↗ 2015

“Dexmedetomidine (DEX) is a highly selective α2 adreno-receptor agonist” NCT05911776 ↗

“Dexmedetomidine (DEX) is a highly selective α2-adrenoceptor agonist” NCT04926454 ↗

“This research study is a continuation of a previous DEX PK study.” NCT03668951 ↗

“Dexmedetomidine (DEX), a selective α (2)-adrenoreceptor agonist.” NCT02720705 ↗

“Dexmedetomidine (DEX) is an a-2 adrenergic agonist for sedation.” NCT04674241 ↗

“Dexmedetomidine (DEX), a highly specific α2-adrenergic agonist” PMID 24627001 ↗ Mar 2014

“Dexmedetomidine (DEX), a selective α2-adrenoceptor agonist” NCT07538284 ↗

“bolus dexmedetomidine (DEX) is immediately discontinued” NCT05785689 ↗

“Dexmedetomidine (DEX) is an alpha-2 adrenergic agonist” NCT06551259 ↗

“among them Dexmedetomidine (DEX).” NCT03877120 ↗

“Drug: Dexmedetomidine (DEX)” NCT07556133 ↗

“Drug: Dexmedetomidine (DEX)” NCT07622355 ↗

“Drug: Dexmedetomidine (DEX)” NCT04912518 ↗

“Dexmedetomidine group (DEX)” NCT03827408 ↗

“Dexmedetomidine (DEX)” NCT07470775 ↗

“Dexmedetomidine (DEX)” NCT07475156 ↗

“dexmedetomidine (DEX)” NCT07072650 ↗

“Dexmedetomidine (DEX)” NCT07519863 ↗
Known as Dex,Dexmedetomidine “Dex,Dexmedetomidine” NCT02552459 ↗
Known as DEX-IN “DEX-IN (Intranasal dexmedetomidine) 50mcg every 6 hours for 48 hours.” NCT02284243 ↗
Known as Dexamed “Dexmedetomidine (Dexamed) is a selective α2-adrenoceptor agonist with sedative and neuroprotective properties, known to reduce ICP without respiratory depression .” NCT07199595 ↗
Known as dexamedetomidine “The needle entry point will be anesthetized with 20 mL 0.25% Rupivacane plus dexamedetomidine 0.25ug/kg.” NCT07368075 ↗
Known as Dexdomitor “Dexmedetomidine Injectable Solution [Dexdomitor]” NCT05123170 ↗
Known as Dexdor “Currently, two pharmacological α-2 agonists, clonidine (Catapressan®, Boehringer Ingelheim) and dexmedetomidine (Dexdor®, Orion Corporation), are marketed and commonly used in...” NCT04758936 ↗
5

“1 µg/kg dexmedetomidine (dexmedetomidine hydrochloride 100 microg/ml, Dexdor® Orion Oyj, Espoo, Finland) diluted in 10 ml of sodium chloride will be administered intravenously...” NCT02724098 ↗

“Dexmedetomidine group (Dex group) : Two administrations of 1 microg/kg of Dexdor® in 250 ml of sodium chloride during 30 min.” NCT03834129 ↗

“It is composed by Dexmedetomidine (Dexdor), Lidocaine, Magnesium Sulfate and ketamine (Ketolar).” NCT05887258 ↗

“Dexmedetomidine (Dexdor®)” NCT02096068 ↗

“Dexdor” NCT04266665 ↗
Known as Dexemedethomidine “Dexemedethomidine is given as major sedative drug” NCT01091818 ↗
Known as DEXM “Dexmedetomidine (DEXM) is a highly selective α2-adrenoceptor agonist that has been used increasingly in pediatric anesthesia.” NCT03791879 ↗
Known as Dexmedetmodine “Dexmedetmodine 50mic (0.5ml) ,4 mg dexamethasone (1ml), 40 mg lidocaine 2% (2ml) added to 4ml total volume with sterile saline .” NCT05271721 ↗
Known as dexmedetomdine “Transforaminal injection of chronic radicular lower limb injection by either dexmedetomdine or magnesuim sulfate” NCT05271721 ↗
Known as Dexmedetomedine “The randomized control trial of Comparison of Ropivacane 0.25% plus Dexamethasone and Ropivacane 0.25% plus Dexmedetomedine will be conducted at department of anaesthesia of...” NCT07368075 ↗
Known as dexmedetomidin “Drug: dexmedetomidin” NCT07166614 ↗
4

“Drug: Dexmedetomidin” NCT07084753 ↗

NCT02544893 ↗

NCT07149168 ↗

NCT05398757 ↗
Known as dexmedetomidine HCl “Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) on Ethanol in Heavy Drinkers With PTSD - Outpatient Study” NCT06335407 ↗
1

“BXCL501 (dexmedetomidine HCl) taken sublingually (under the tongue) in the ED and at bedtime over 2 weeks.” NCT06943404 ↗
Known as Dexmedetomidine HCl Injection “Dex (Precedex, Dexmedetomidine HCl Injection) is produced by Pfizer Inc, NY, Ny (formerly Hospira).” NCT03355053 ↗
Known as Dexmedetomidine Hydrochloride “1 µg/kg dexmedetomidine (dexmedetomidine hydrochloride 100 microg/ml, Dexdor® Orion Oyj, Espoo, Finland) diluted in 10 ml of sodium chloride will be administered intravenously...” NCT02724098 ↗
39

“Dexmedetomidine hydrochloride ,a relatively new drug in Chinais ,is a highly selective, potent a2-adrenoceptor agonist with significant analgesic, sedative and anxiolytic effects.” NCT01864187 ↗

“Dexmedetomidine hydrochloride as a single agent produces sedation, pain relief, anxiety redution, stable respiratory rates, and predictable cardiovascular responses.” NCT00691886 ↗

“Study drugs (either 200 μg/2 ml dexmedetomidine hydrochloride or 2 ml 0.9% saline) were provided as clear aqueous solution in the same type of 3 ml volume ampules” NCT03117790 ↗

“A single vial contains an injection solution with 2 mL of dexmedetomidine hydrochloride solution (100 µg/mL as dexmedetomidine) dissolved in physiological saline” NCT02757625 ↗

“Patients in the Opioid Sparing group will receive a dexmedetomidine (PRECEDEX™ "dexmedetomidine hydrochloride" - Pfizer) and ketamine.” NCT05674877 ↗

“Dexmedetomidine hydrochloride (Precedex®, manufactured by Hospira, Inc. Lake Forest, IL, and USA) is supplied in 100 μg/ml ampule.” NCT03064633 ↗

“The nasal spray group (Group D) trial medication specification is dexmedetomidine hydrochloride nasal spray at 25μg per spray.” NCT07579806 ↗

“Dexmedetomidine hydrochloride (PrecedexTM), presented in ampoule containing 2 mL of 100 mcg / mL solution for injection” NCT03290625 ↗

“dexmedetomidine (dexmedetomidine hydrochloride 100 μg/ml, Precedex® Abbott Laboratories North Chicago, IL 60064, USA)” NCT01084473 ↗

“Group 1 (LD) was administered 50 μg of dexmedetomidine hydrochloride nasal spray and 50 μg of placebo nasal spray” NCT07298525 ↗

“Use of Dexmedetomidine Hydrochloride 5 micrograms (1 mL) as an adjuvant with bupivacaine hydrochloride” NCT05993975 ↗

“Dexmedetomidine Hydrochloride is a novel highly-selective α2 adrenergic receptor agonist” NCT03346226 ↗

“100 mcg/mL dexmedetomidine hydrochloride; Precedex, Hospira Inc, Lake Forest, IL” NCT05775861 ↗

“Dexmedetomidine Hydrochloride: PrecedexR 200 µg/2ml vial , Pfizer, Egypt.” NCT06958367 ↗

“Dexmedetomidine Hydrochloride which is an Alfa 2 receptor agonist” NCT05850455 ↗

“Drug: Dexmedetomidine Hydrochloride 0.5 MG/ML” NCT06354478 ↗

“Drug: Dexmedetomidine Hydrochloride 0.1 MG/ML” NCT03817112 ↗

“Drug: Dexmedetomidine Hydrochloride 0.1 MG/ML” NCT04652427 ↗

“dexmedetomidine hydrochloride nasal spray” NCT07550881 ↗

“Precedex, dexmedetomidine hydrochloride” NCT04082767 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT00142493 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT03596424 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT03312413 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT04042727 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT05342376 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT04409964 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT05489900 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT04906889 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT03234660 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT04772222 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT06720220 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT03530371 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT05175781 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT06808295 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT05552391 ↗

“Drug: Dexmedetomidine Hydrochloride” NCT06366412 ↗

NCT06417125 ↗

NCT04260659 ↗

NCT04942340 ↗
Known as dexmedetomidine hydrochloride for injection “dexmedetomidine hydrochloride for injection (200 ug/2 ml) will be diluted with normal saline to 50 ml (final dexmedetomidine concentration 4 ug/ml).” NCT03289325 ↗
Known as Dexmedetomidine Injection “Dexmedetomidine Injection [Precedex]” NCT04659642 ↗
2

“Dexmedetomidine Injection [Precedex]” NCT06386783 ↗

“Drug: Dexmedetomidine injection” NCT06410365 ↗